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ABSTRACT 
The European Food Safety Authority (EFSA) received in December 2011, a request from the European 
Commission for an update on the possible scientific developments for cloning of farmed animals for food 
production purposes. The present Statement follows the EFSA 2009 and 2010 Statements and the EFSA 2008 
Scientific Opinion, and is based on peer reviewed scientific literature published since the EFSA 2010 Statement, 
information made available to EFSA following a call for data, and discussions with experts in the field of animal 
cloning. As reported before, Somatic Cell Nuclear Transfer (SCNT) can produce healthy clones, but a portion of 
the animal clones suffered from developmental abnormalities likely due to epigenetic dysregulation (incomplete 
nuclear programming) and died at various stages of development. For some of the live animal clones, in 
particular calves and piglets, health and welfare were compromised specifically within the perinatal and juvenile 
period. Also some of the surrogate dams were affected due to abnormal pregnancies. Food products from healthy 
clones, i.e. meat or milk, did not differ from products from healthy conventionally bred animals. The offspring of 
clones and their food products showed no differences with conventional offspring or products. Data on clones of 
farmed species for food production other than cattle and pigs have remained limited and do not allow for the 
assessment of food safety or animal health and welfare aspects. The cloning efficiency, defined as the number of 
live offspring as a proportion of the number of transferred embryos, remained about 6-15 % for cattle and about 
6 % for pigs. When compared with in vitro fertilisation (IVF), for which the background percentage of live 
offspring per transferred embryo is 45-60%, the efficiency of cattle SCNT relative to IVF is 13-25%. To 
overcome the relatively low cloning efficiency researchers continue to amend cloning procedures, with limited 
improvements shown by some researchers.  
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SUMMARY 
The European Food Safety Authority (EFSA) received in December 2011, a request from the 
European Commission for an update of the possible scientific developments of cloning of farmed 
animals for food production purposes. 
The present Statement follows the EFSA 2009 and 2010 Statements and the EFSA 2008 Scientific 
Opinion, and is based on peer reviewed scientific literature published since the EFSA 2010 Statement, 
information made available to EFSA following a call for data, and discussions with experts in the field 
of animal cloning.  
Cloning by Somatic Cell Nuclear Transfer (SCNT) in cattle and pigs has produced healthy clones and 
healthy offspring that are similar to their conventional counterparts based on parameters such as 
physiological characteristics, behaviour and clinical status. With respect to food safety, there were no 
indication that differences exist for products (i.e. meat and milk) of healthy clones and their offspring 
compared with those from healthy conventionally bred animals. Data on clones of farmed species for 
food production other than cattle and pigs have remained limited and do not allow for the assessment 
of food safety or animal health and welfare aspects. 
Health and welfare were compromised in a proportion of clones, mainly observed as increased 
mortality within the postnatal and juvenile period of calve and piglet clones, as well as in a proportion 
of the surrogate dams that were affected by abnormal pregnancies. For cattle and pig clones, 
epigenetic dysregulation remained the main source of anomalies throughout development. The 
majority of reports published over the last 2 years covers research to try to overcome this 
dysregulation. So far, no major breakthroughs have been reported on improved overall cloning 
procedures that would result in an increase of the SCNT cloning efficiency calculated as the number of 
live offspring as a proportion of the number of transferred embryos. This efficiency is still in the range 
of 6-15% for cattle and of 6% for pigs, albeit occasionally higher success rates were reported. If the 
comparator for cattle cloning is in vitro fertilisation (IVF), the background (i.e. the percentage of live 
offspring per transferred embryo from IVF) is 45-60% and the efficiency of SCNT when compared to 
IVF can be calculated as 13-25%. 
No new elements have emerged that would change the previous EFSA Opinion on the possible 
environmental impact of cloning: i.e. cloning in itself of farmed animals poses no particular threats for 
genetic diversity or biodiversity; and from the limited data available there are no indications that 
would suggest new or additional environmental risks from farmed animal clones when compared to 
conventionally bred farmed animals. There is also no information available to suggest that such risk 
may exist. 
No new information has become available since the EFSA 2009 and 2010 Statements and the EFSA 
2008 Scientific Opinion that would lead, at this point in time, to a reconsideration of the conclusions 
and recommendations related to the food safety, animal health and welfare aspects, and environmental 
aspects of animal cloning of the 2008 Scientific Opinion and the 2009 and 2010 Statements of EFSA. 2012 Update on cloning of farmed animals
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BACKGROUND  
As announced in its request to EFSA for the 2010 update on cloning, the European Commission 
presented a report on somatic cell cloning to the European Parliament and to the Council end 2010, 
providing details on the market situation of animal clones, their offspring, breeding material, and food 
products obtained from such animals. The European Commission report reviews science based issues 
related to the health and welfare of the animals as well as food safety issues as raised by EFSA in 
2008, 2009 and 2010 (EFSA, 2008, 2009, 2010). 
The European Commission is spear-heading regulatory debates on somatic cell cloning that explore 
potential measures on animal cloning for food production in the EU. An impact assessment on the 
possible measures on animal cloning for food production in the EU has begun and is planned to be 
finalised by the end of 2012. Based on this impact assessment a legislative proposal on animal cloning 
for food production is envisaged for 2013, with input from stakeholders and a report provided by an 
external contractor on the possible economic, social and environmental impact of these possible 
measures.   
The main issues reported in the EFSA 2008 Scientific Opinion on “Food Safety, Animal Health and 
Welfare and Environmental Impact of Animals derived from Cloning by Somatic Cell Nucleus 
Transfer (SCNT) and their Offspring and Products Obtained from those Animals” and the 2009 and 
2010 updates were as follows. There were limited numbers of studies reported for clones of farmed 
animals other than cattle and pigs; the health and welfare of a proportion of clones were found to be 
adversely affected, often severely and with a fatal outcome at a juvenile stage; there were no 
indications of any differences in food safety for the meat and milk of clones and their offspring when 
compared with conventionally bred animals; and no environmental impacts were envisaged, though 
the limited availability of data was acknowledged. There was also no information available to suggest 
such risks may exist. The main source of the adverse effects that may affect clones and result in 
developmental abnormalities was epigenetic dysregulation; the failure of the placental development 
following cloning was considered to be one of the reasons why the technique has a low success rate; 
adverse affects, however, varied between species. For example, as for other assisted reproductive 
technologies, large offspring syndrome (LOS) affects SCNT cattle but not SCNT pigs. This condition 
could result in difficult birth and health problems for the surrogate dams and cases of stillbirth. Neither 
of these phenomena appeared to affect the offspring of clones born through conventional breeding 
protocols. Cloning could contribute to breeding in a more rapid manner of farmed animals that show 
improved parameters on resistance to the common pathologies (e.g. mastitis, other infectious and 
parasitic diseases), fertility, welfare and others related to the general robustness of the animal. With 
respect to the concern that cloning might decrease genetic diversity, it is noted that if used 
appropriately, in connection with suitable management measures, cloning is not expected to adversely 
affect the genetic diversity among domestic species.  
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
Following the failure of the Conciliation procedure in March 2011 of the Novel Food Regulation, the 
Commission is examining the possibility to introduce a legislative proposal on cloning. 
A comprehensive impact assessment on all aspects of cloning is foreseen before adopting the possible 
legislative proposal on cloning. 
The EFSA Statements of 2010 and 2009 confirmed the EFSA Scientific Opinion of January 2008. The 
Commission would again appreciate an updated assessment of the current situation as regards the 
scientific developments in this area.  
By this letter, it is formally requested to provide an update on the state of play on the possible 
scientific developments on the issue of cloning of farm animals for food production purposes. 
The update would be appreciated by the end of June 2012
4.  
                                                      
4 The request letter of the European Commission is accessible at http://registerofquestions.efsa.europa.eu/ under 
the question number EFSA-Q-2011-01270. 2012 Update on cloning of farmed animals
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ASSESSMENT 
1.  INTRODUCTION 
Cloning of farmed animals aims at producing healthy and fertile offspring through somatic cell nuclear 
transfer (SCNT) or embryonic cell nuclear transfer (ECNT). For SCNT, a wide variety of nucleus 
donor cells can be used from adult somatic tissues, while for ECNT, donor nuclei come from an early 
embryonic stage (and therefore require less reprogramming).  
To be successful, a number of steps have to be made correctly during the cloning process. First, the 
donor nucleus carrying the desired genetic material should be chosen with care so that it is capable to 
remodelling and subsequent genomic reprogramming. That nucleus is then introduced into an 
enucleated oocyte cytoplasm capable of facilitating the nuclear remodelling. Further, this 
reconstructed oocyte needs to be adequately stimulated to initiate pre-implantation development, for 
which the culture environment must be compatible with the physiological requirements of the 
particular embryo. As from here, the steps of the cloning process are the same as in other assisted 
breeding methods: the embryo is transferred into a surrogate dam and the birth may be by natural 
delivery or by Caesarean section.  
Much has been learned about the changes that occur to a nucleus after it is placed in the cytoplasm of 
an oocyte and about the effects of adapting culture conditions for embryo development. While the 
understanding of the reorganization that occurs is increasing, and successful SCNT clones continue to 
be produced around the globe, the process of cloning is still inefficient due to incomplete 
reprogramming. This may lead to aberrant gene expression profiles during the pre-implantation 
development, foetal development, and abnormal health conditions of neonates and young growing 
animals. Below, while reviewing the reported results of mainly SCNT (as there are very few data on 
ECNT), nuclear remodelling and reprogramming will be discussed, as well as techniques that may 
improve reprogramming. 
Animal cloning is intended to produce virtually identical genetic copies of the donor animal to yield 
identical phenotypes. The animal clones, however, are very similar to their genetic source, but not 
completely identical from a genetic point of view: the usual degree of mutations may be present in the 
chromosomal genomes and the mitochondrial genomes will be different. These animal clones, may 
also have slightly different phenotypes due to individual variation in their epigenetic status, and due to 
contributions from the cytoplasm of the recipient oocytes. 
Unless otherwise stated, the information in the current Statement refers to intra-species SCNT. 
Cloners switched from ECNT to SCNT in the early 2000s, because the latter allows to access a larger 
source of nuclei of the same genotype, to pre-select the gender of the clone and to select from of a 
larger amount of desirable known phenotypes. Therefore, this Statement does not assess the safety of 
the ECNT procedure, although limited available data sets have included ECNT clones and are reported 
herein. Results from inter-species SCNT are not included in this Statement. 
The aim of this Statement is to identify recent information pertinent to the efficiency of cloning of 
farmed animals and its consequences for longevity and animal health and welfare of surrogate dams, 
clones and their offspring. These last parameters, falling within the remit of EFSA, were identified 
previously as areas of concern when applying cloning for animal breeding. 
Ethical
5, economic and socio-cultural concerns or benefits regarding cloning of farmed animals fall 
outside EFSA’s remit for science-based risk assessment and are not addressed in this Statement. 
                                                      
5 http://ec.europa.eu/bepa/european-group-ethics/docs/publications/opinion23_en.pdf 2012 Update on cloning of farmed animals
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2.  SPECIES OF FARMED ANIMALS CLONED FOR FOOD PRODUCTION PURPOSES 
Previously, EFSA reported (EFSA 2010) that somatic cloning has been successfully used in 22 
different species and that most laboratories work on farmed animals, particularly on bovine, porcine, 
ovine, caprine, and equine species. It needs to be noted however, that clones of other species and their 
offspring, for instance rabbits, mule, buffalo and deer, could potentially enter the food chain. This 
Statement focuses on cloning of farmed animals species that are used for food production in Europe. 
Consequently, cloning of additional species such as elephant and raccoon, as reported recently, is not 
covered herein. 
 
3.  PURPOSES OF CLONING FARMED ANIMALS FOR FOOD PRODUCTION 
The main reason for cloning farmed animals is to produce elite livestock for meat and milk production 
(e.g. Watanabe, 2011). Clones of elite animals give insurance for or facilitate the breeding for the elite 
quantitative and qualitative traits, such as milk and meat quantity and quality. Other traits that 
characterise an elite animal might be the resistance to disease (e.g. mastitis, other infectious and 
parasitic diseases) or improved fertility. Another reason for cloning is to preserve a particular type of 
wild-life species or domesticated ecotype. Indeed, the capacity of preserving extinct animals and 
maintaining genetic diversity through cloning has also been successfully applied for domesticated 
species such as native Anatolian grey cattle (Arat et al., 2010; 2011) and for companion animals. Since 
this Statement is dedicated to cloning of farmed animals for food production, the cloning of farmed 
animals for purposes other than for food production is not included herein. 
 
4.  CHANGES TO CLONING PROTOCOLS FOR FARMED ANIMALS OVER THE LAST 2 YEARS  
As mentioned in the introduction, current cloning protocols are composed of many different steps and 
inefficiencies are most likely due to incomplete or faulty reprogramming of the genome of the donor 
cell. Further studies on epigenetic reprogramming of farmed animal clones have been performed and 
provide some new insights into the fundamental biology of epigenetic reprogramming processes 
themselves as well as in the way to optimize them. Indeed, there have been contributions of farmed 
animals to the scientific understanding of animal cloning as epigenetic reprogramming, epigenetic 
alterations versus (ab)normal phenotype, and the concept of clones as epigenome variants has been 
further documented in farmed animals.  
Many research groups worked on the handling of somatic nucleus donor cells and recipient 
enucleated oocytes (ooplasms) at the level of embryo reconstruction and activation conditions. 
Under the hypothesis that alterations frequently associated with SCNT stem from the initial 
remodelling of the somatic nucleus and/or from the early reprogramming of genes that control the first 
steps of development, several attempts were made to modulate the remodelling and early 
reprogramming events of the somatic nuclei by modifying their micro-environments when in culture 
to determine whether it is possible to increase yield of blastocysts and the efficiency of cloning. The 
duration of exposure of the somatic nucleus to ooplasm factors before induction of the activation 
process that initiates development, and the activation process itself, are also critical steps of any 
cloning procedure. These steps were investigated by several research groups; however, so far no 
marked advances were reported over the last 2 years. 
 
Other research focussed on the in vitro culture conditions of early developing embryos in order to 
unravel further nuclear remodelling and genomic reprogramming in relation to epigenetic 
modification occurring in the genome. Progress in cellular imaging and high-throughput molecular 
analysis of DNA methylation and histone modifications stimulated an already active field of research 
including epigenetics, stem cell biology, reproductively biology, and veterinary sciences. In this 
context, SCNT-derived embryos of farmed animals were often used as models to extend observations 
made in the mouse. Such mouse experiments have for instance aimed at altering the micro-
environments of the embryos to make it compatible with a more complete nuclear reprogramming and 
ultimately resulting in improvements in SCNT efficiency. However, few papers provide an in vivo 2012 Update on cloning of farmed animals
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validation of observations made in vitro, mainly because of the costs of experiments with large farmed 
mammals. 
 
Also the risks of disease transmission through cloning has been addressed. Some data on the 
potential disease transmission through cloning have become available and show that risks are reduced 
to negligible when appropriate precautions are adopted in the SCNT embryo production and transfer, 
in line with published guidance documents (e.g. by the International Embryo Transfer Society IETS). 
Yet other studies have analysed the foetal and placental development with respect to epigenetics and 
late emerging effects thereof. Abnormal implantation and placenta formation have been frequently 
observed after transfer of SCNT embryos into recipient surrogate dams. These contribute to the low 
efficiency of cloning and are the main origin of most of the welfare problems encountered by recipient 
surrogate dams around birth. The gene expression profile in the placenta and at foetal stages has been 
studied as well as the physiological features of clones. Incomplete nuclear reprogramming after SCNT 
and failure to re-establish appropriate epigenetic marks during development, particularly in regions 
controlling the expression of imprinted genes, are considered as the major causes of pregnancy failure 
with SCNT embryos. Some improvements have been made over the past two years to the analysis of 
pregnancy dysfunctions but these have not yet led to marked improvements in the reduction of 
pregnancy failures with SCNT embryos in farmed animals.  
At this stage, one or more improvements made to cloning procedures cannot be considered as common 
for all species nor as a major breakthrough during 2010-2012. Suboptimal nuclear reprogramming 
remains to be considered a main cause of pathologies and mortalities in clones.  
Cattle and pigs are the two leading species in terms of numbers of published papers and propositions 
for improving technical cloning protocols, which differ between the two species. However, several 
advances in efficiency gains obtained during 2010-2012 but in the mouse academic animal model - 
where potentially controllable reprogramming errors have been identified - may be expected to 
steadily lead to improvements per species (incl. animals with long production cycles, such as farmed 
animals).  
Furthermore, techniques for prediction of pregnancy outcomes and the health prognosis of 
growing foetuses are in development. Advances in the medical uses of such techniques (e.g. of 
imaging techniques) are being considered for increasing the prognostic evaluation of clone pregnancy 
outcome. 
An overview of marked studies from the last 2 years in the above-mentioned areas for changing the 
cloning protocol for farmed animals is given and referenced in Appendix 1. 
 
5.  CURRENT EFFICIENCY RANGES OF CLONING IN CATTLE AND PIGS 
5.1.  Efficiency range calculations 
Watanabe and Nagai (2011) evaluated cloning efficiencies as the numbers of (1) pregnant recipient 
surrogate dams, (2) calves born, (3) calves living at birth, (4) calves living at 24 h, and (5) calves 
living at 6 months,  as a percentage of SCNT embryos transferred into recipient surrogate dams. 
Cloning efficiencies can thus reflect different things, such as the implantation rate of the embryos, or 
the pregnancy rates, or the percentage of live births, or the proportion of live and healthy adult clones. 
For cattle, in which 1-2 embryos are implanted per surrogate dam, helpful information can be derived 
from calculating general cloning efficiency as the number of healthy clones that live past the juvenile 
stage compared with the number of recipient surrogate dams of transferred SCNT embryos. Wider use 
of one uniform calculation would allow research results to be more readily compared. 2012 Update on cloning of farmed animals
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Basing the calculation on the number of healthy clones that live past the juvenile stage 
informs about the full success of the process, including the element of health and welfare of 
clones and their surrogate dams. On the other hand, calculations based on live births only are a 
good indicator of the nuclear reprogramming capacity, meanwhile excluding post-natal deaths. 
Post-natal deaths can indeed be due to other reasons than the cloning and can be linked to the 
herd management. 
Calculations based on the number of recipient surrogate dams of transferred SCNT embryos 
and not only on the pregnant recipients, also takes into account all of the surrogate dams used, 
including those which did not become pregnant. 
Calculations based on the number of transferred SCNT embryos, instead of surviving animal 
clones, would also include the proportion of natural embryonic mortality (abortions as part of 
natural selection) during the first days after fertilisation. These mortalities occur in any species 
at rather high frequencies; e.g. 35-50% for cows (Sreenan and Diskin, 1986; Sreenan et al., 
1997) and 30-40% for pigs (Bolet, 1986; Lambert et al., 1991). 
The above calculation (the number of healthy clones that live past the juvenile stage compared with 
the number of recipient surrogate dams of transferred SCNT embryos), can also be applied to pig 
cloning. The domestic pig is a multiparous species with an average litter size of 10-12 and under 
current cloning practice receives up to 100 or more SCNT embryos per surrogate dam, depending on 
embryo quality at day of transfer. Therefore, there are two additional parameters to assess cloning 
efficiency for pigs; the first is the number of pregnant and delivering surrogate dams per total 
surrogate dams; the second is the average litter size per recipient surrogate dam. 
5.2.  Variability and comparators for efficiency ranges 
Efficiencies of cloning vary not only between species, but even between the type of donor cells, 
genotypes and culture medium conditions. Variations are important between donor cell lines, as one 
quarter of donor cells never develop into live offspring (results in cattle reported by Panarace et al. 
(2007)). No new data that inform about this variability have been reported.  
EFSA considers that cloning efficiency should not be compared with natural breeding since the 
objective of cloning is not to be an alternative for natural breeding but for other ART techniques based 
on in vitro fertilization. However, it should be noted that background success rate of conventional 
reproduction with AI, as the number of females that did not return to oestrous cycles after 
insemination, is in the range of 55-60 % for cattle under farm conditions and 45-55% for pigs. 
Importantly, the factors that cause pregnancy failure here, are equally present for pregnancies of 
recipient surrogate dams carrying SCNT embryos. For IVF in cattle, the background success rate as 
the percentage of live offspring per transferred embryo is 45-60% (Chavatte-Palmer et al. (2012), 
reviewing original data published by Hill et al. (2000) and Heyman et al. (2002)), and again the factors 
that cause failure for IVF are acting for cloning as well. 
Furthermore, if a given % of cloning efficiency would be compared to yield a relative efficiency, it 
should only be with efficiencies of other techniques using in vitro produced embryos of the same 
species, not in vivo embryos; this is to take into account the efficiencies of standard species-specific 
embryo transfer procedures. For example for cattle, the SCNT percentage of live offspring per 
transferred embryos is 6-15% (Chavatte-Palmer, 2012), see section below. If the comparator is cattle 
IVF, then the background percentage of live offspring per transferred embryo is 45-60% (Chavatte-
Palmer, 2012) and the efficiency of cattle SCNT relative to IVF can be calculated as 13-25%. If the 
comparator would be AI, then the background is 55-60% and the efficiency of cattle SCNT relative to 
AI can be calculated as 11- 25%. 2012 Update on cloning of farmed animals
 
EFSA Journal 2012;10(7):2794  9
5.3.  Efficiency ranges for SCNT in cattle and pigs 
So far, no major improvements in cloning efficiency of farmed animals have been published since the 
EFSA 2010 Statement. Therefore, the efficiency of cloning as previously described for cattle and pigs 
(EFSA, 2010), and expressed as the number of live offspring as a proportion of the number of 
embryos transferred, remains approximately 6-15 % for cattle and 6 % for pigs. There are occasional 
reports from companies offering commercial cloning services indicating that success rates for cattle as 
high as 40% can be obtained provided the entire chain of the SCNT cloning process, including for 
example the choice of donor cells and the delivery of the clones, has been optimised. EFSA notes that 
mere refinements of overall cloning protocols to increase cloning efficiency are unlikely to be 
published in peer-reviewed journals due to their lack of hypothesis generating issues, and the 
likelihood that many of these improvements may be the proprietary information of private concerns.  
Recent calculations for cattle cloning efficiency in Japan
6 were provided by Watanabe and Nagai 
(2011) on the basis of clones living from 1998-2007. These calculations were based on higher 
numbers of SCNT clones (e.g. 301 SCNT calves) and confirmed the previously cited ranges for cattle 
reported in the EFSA (2010) Statement. While the authors report 8 % as the number of live births as a 
proportion of the number of transferred embryos, the cloning efficiency calculated as the number of 
healthy clones that live past the juvenile stage as a proportion of the number of transferred embryos is 
reduced below 5% due to a considerable amount of post-natal deaths. For additional information on 
health and welfare observations of live clones in Japan, see Section 6. 
For pigs, Schmidt et al. (2010) reported 7.3% ±0.6% as the mean rate of born SCNT piglets as a 
proportion of transferred embryos into Large White (LW) sows. Liu et al. (2010) using the Guangxi 
Bama minipig also found that the efficiency of cloning was low: 4 recipients and 328 SCNT embryos 
resulted in just one male pig clone. Schmidt et al. (2010) achieved greater pregnancy rates and larger 
litter sizes (6.1 vs 4.2) by increasing the number of transferred embryos further (60-120 embryos 
compared with less than 60) and when the embryos were placed into both uterine horns rather than 
into just one (74% vs 44% delivery rate). They took into account that highly-inbred minipigs generally 
have reduced fertility and litter size. 
 
6.  HEALTH AND WELFARE OF ANIMALS INVOLVED IN THE CLONING PROCESS 
For cattle, earlier EFSA Statements highlighted concerns over the health and welfare of a proportion 
of the surrogate dams, and a proportion of the clones at various stages of development (but not for the 
offspring of clones). The health and welfare of some of the surrogate dams of clones can be adversely 
affected due to complications in pregnancy from abnormal placentation (e.g. abortions, placental 
deformities, large foetuses). Abnormalities of some of the clones were found during the perinatal 
period (joint anklyosis, respiratory disease) with other problems reported up to 6 months of age. It is 
noted that these types of abnormalities observed are not unique to clones and occur also during 
conventional breeding albeit at lower frequencies. It has also become clear that once clones have 
survived the neonatal period and have reached approximately 6 months of age (cattle), further 
development appears normal. Sexually reproduced offspring of clones appeared normal at all stages of 
development. The literature from the past 2 years on health and welfare of cattle and pig clones, 
sexually reproduced offspring of clones, and surrogate dams is summarised below. 
6.1.  Health and welfare of surrogate dams  
Cattle: Foetal overgrowth and loss of allometric growth regulation, collectively known as large 
offspring syndrome (LOS), is one of the most common SCNT foetal phenotypes, along with 
placentomegaly (Chavatte-Palmer et al., 2012; Constant et al., 2011; Kohan-Ghadr et al., 2011). Out 
of 20 SCNT pregnancies reported by Kohan-Ghadr et al. (2011), 12 pregnancies did not proceed to 
                                                      
6 Some technological peculiarities in the Japanese practice in recent years (cold storage of ovaries for an 
extended period of time, in order to check the BSE status of the donors) has resulted in a reduction of live births, 
creating a slight negative bias in the data compared with other countries. 2012 Update on cloning of farmed animals
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term: (1) therapeutically aborted for humane reasons (N=4), (2) delivered via Caesarean section 
(N=3), or (3) spontaneously aborted (N=5). Abnormal placentation was observed; the placentomes 
were larger and longer than normal, especially during the last trimester. Chavatte-Palmer et al. (2012) 
reported that pre- and post-implantation losses can affect up to 70% of pregnancies. They further 
observed that steroidogenesis during pregnancy was perturbed and that abnormal oestrogen production 
and metabolism probably play an important part in the increased gestation length as frequently 
observed with clones. This may have welfare implications as longer pregnancies can lead to larger calf 
sizes and a higher chance of dystocia, although this also happens in non-clones. Kohan-Ghadr et al. 
(2011) found that at day 80 of pregnancy, progesterone concentrations were lower in surrogate dams 
carrying clones than in controls, whereas oestradiol levels and pregnancy-specific protein B were 
higher than in conventionally-produced pregnancies (Chavatte-Palmer et al., 2012). Placental glucose 
transport and fructose synthesis also appeared to be modified in neonatal clones, and gene expression 
analyses of the bovine SCNT placenta showed that multiple pathways and functions were affected 
(Chavatte-Palmer et al., 2012). Plasma glucose concentrations were lower in surrogate dams with 
clones than in the control group at day 257 of pregnancy and at parturition (Hirayama et al., 2011). It 
was also observed that the plasma glucose concentration at term was lower than normal. As such, this 
is not considered to create a health problem for the surrogate dam. In view of the fact that the birth 
weight of the clones was significantly higher than that of the control group, reduced maternal glucose 
levels could allow a rough prediction of the occurrence of LOS at least after the 4
th week pre-
parturition and could help to decide on an early Caesarean delivery.   
Pigs: Schmidt and co-workers (2011) found an overall pregnancy rate (defined as the number of 
pregnant sows compared with the number of sows that have received embryos) of 62% in Large White 
(LW) sows carrying SCNT embryos, with 26% of the pregnancies aborting or resorbing at around day 
35 of pregnancy. With LW litters, 59 piglets (+ 3 mummies) were born in total from 15 pregnancies: 
47 piglets were born alive, while 12 (+ 3 mummies) were born dead (Schmidt et al., 2010). Of the 47 
piglets born alive, 8 were dead in less than 10 days. The authors found several placental abnormalities 
such as endometrial oedema in 14 sows delivered by Caesarean section.  
Watanabe (2011) reviewing pig cloning in Japan (Duroc and Jin-Hua breeds) recorded that 97.8% of 
the surrogate dams were induced for birth and that 24.4% of the foetuses were stillborn compared with 
5.6% of births from conventionally bred pigs. Schmidt et al. (2011) found that stillbirths in 
spontaneous deliveries by LW and minipigs were higher than in induced deliveries (56% vs 24%) with 
deaths often being caused by asphyxia (no further details given). The latter observations could be 
explained by the lack of correct hormonal balance often observed with term SCNT foetuses that do not 
engage in the delivery as normal. This is considered to be the physiological reason for the prolonged 
pregnancies and delivery problems with clones. Induced deliveries can reduce the proportion of 
stillbirths and the proportion of surrogate dams suffering from these abnormal deliveries; however this 
proportion still remains higher than for the conventionally bred animals.  
6.2.  Health and welfare of clones 
Cattle:  
Studies of clones in Japan (Watanabe, 2011) show that those animals surviving for more than 200 days 
were no different to normal animals in terms of health status, growth rate, fertility and production of 
meat and milk. However, in the first 30 days of life, losses due to disease in clones (SCNT) were 
higher than in conventional animals (CV) (see Table 1). For a group of 17 calves, large offspring 
syndrome (LOS) symptoms were examined: 1 to 3 days after birth 6/17 (35.3%) of these died of 
respiratory disease and 2/17 (11.8%) died due to deformed hearts. After the 4th day after birth, deaths 
by pneumonia were observed, but no figures were given. 2012 Update on cloning of farmed animals
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Table 1:   Observations of deaths due to disease in SCNT cattle (Watanabe, 2011). SCNT = Somatic Cell Nuclear 
Transfer Clones, CV = Conventional animals, CP = Progeny from SCNT Clones crossed with CV, sd = significantly different, nsd = not 
significantly different, * = sd at p = or < 0.05 from CP and CV. 
Death due to disease  Nr of death animals out of the total numbers studied
(a) (%)  Probability 
 SCNT
(b) CV  CP   
Overall  94/482 (19.5%)   Figures not given  14/202 (6.9%)   
Stillbirths 
  79/482 (16.4*%)  26/566 (4.6%)  18/202 (8.9%) 
SCNT sd to CP 
and CV  
(p <0.05). 
CV and CP nsd 
Neonatal (< 24h)  65/451 (14.4*%)  11/566 (1.9%)  1/124 (0.8%) 
SCNT sd to CP 
and CV  
(p <0.01). 
CV and CP nsd 
2 - 150 days  72/307 (23.5*%)  55/1289 (4.3%)  5/111 (4.5%) 
SCNT sd to CP 
and CV (p <0.01). 
CV and CP nsd 
150-300 days   5/202 (2.5*%)  6/1207 (0.5%)  0/94 (0%)   SCNT sd to CV 
(p <0.01). 
300-720 days        No significant 
differences 
After 720 days        No significant 
differences 
(a):  When examining data in Table 1, it is important to consider that the cattle population groups addressed in this Table are 
data obtained at one point in time available from the national survey in Japan. Therefore, while the horizontal 
comparison between groups (i.e. SCNT clones versus conventional animals or clone progeny at the same point in time) 
is valid, a vertical comparison (over time) is not. Therefore, it is not possible from Table 1 to draw any precise 
conclusion on how many animals in a specific cattle group died at birth, during the neonatal period, between 2 and 150 
days, between 150 and 300 days or later, although general information on lethality observed at different ages among 
cattle clones, conventional cattle and clone progeny can be derived.  
(b):  For some of the numbers ECNT clones might be included. 
 
In another report, Watanabe and Nagai (2011) described survival rates of transferred bovine embryos 
and the percentage of calves derived from SCNT had not improved over a decade (1998–2007). A 
feature of SCNT embryos was the high incidence of spontaneous abortions, with 8.3– 27.1% of the 
pregnant recipient surrogate dams losing their foetuses after 100 days of gestation. These survival 
rates are lower than those for foetuses bred by multiple ovulation and embryo transfer (MOET) or in 
vitro production (IVP). The variation in survival rates for SCNT calves at birth, 24h and 6 months 
were 4.6–11.0%, 3.4–9.1% and 2.2–7.5%, respectively.  
In another pool of 25 neonatal calf clones, 22 suffered from respiratory disease, 9 of which required 
ventilator support (intra-nasal oxygen); 3 of these later died and one was euthanised (Brisville et al., 
2011).  
 
Chavatte-Palmer et al. (2012) observed that neonatal calves had high fructose levels although blood 
glucose levels were normal. Also a previous report showed that surviving SCNT clones have 
haematology and clinical chemistry values for plasma glucose within normal ranges (Hirayama et al., 
2011).  
 
Ten cow clones obtained from oviduct cells and which had shortened telomeres, had reached the age 
of 5 years (Miyashita et al., 2011). These clones have delivered healthy offspring with normal 
telomere length after AI with semen from conventional animals. However, the authors found evidence 
of poor wound healing, alopecia, rough hair, wrinkled skin and lameness in one of the two groups of 
clones with shortened telomeres. When the above ten clones with shortened telomeres were 3 years 
old, they appeared to be normal based on growth rate, time of onset of puberty, age at first conception, 
calving interval, gestation length; and also volume milk (compared with the cows from which they 
obtained the donor nucleus). In this experiment, also one clone was generated from uterus cells which 2012 Update on cloning of farmed animals
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did not have shortened telomeres. The authors also described considerable variation in telomere length 
in the normal control population and in the clinical signs shown by animals with varying telomere 
sizes. No direct relation between telomere length and aging of clones could be demonstrated. 
 
The ontogeny of disease observed with certain clones in relation to defective reprogramming of 
different classes of genes, here imprinted genes, has also been studied:  
 
During the SCNT process itself, the nuclear DNA of the donor adult somatic cell that is transferred 
into an unfertilised oocyte, needs to be reprogrammed for the development of different tissues. Some 
of the defects of such reprogramming are not observed until after birth and one of these is for Mash2, 
an imprinted gene that plays an important role in embryogenesis and embryo development. Imprinted 
genes are expressed differently based on parental inheritance. Since lungs of deceased bovine clones 
often exhibit aberrations, the methylation status of Mash2 was checked in such samples. Chen et al. 
(2010) concluded that Mash2 was abnormally methylated in these animals, which may have 
contributed to aberrant lung development and the low survival of these clones.  
Couldrey and Lee (2010) compared a panel of imprinted, non-imprinted and satellite repeat sequences 
in mid-gestation SCNT clones. Various tissues were collected from viable and failing mid-gestation 
SCNT foetuses and compared with similar tissues from gestation-matched normal foetuses generated 
by AI. Most of the genomic regions examined in tissues from viable and failing SCNT foetuses had 
DNA methylation patters similar to those in the control tissues. However, specific DNA regions rich 
in CG nucleotide basepairs (CpG sites) in only some regions of the genome tend to be hypomethylated 
only in SCNT tissues. Also, DNA methylation pattern in tissues of failing SCNT foetuses were similar 
to apparently viable SCNT foetuses, although there were individuals showing extreme deviant 
patterns. Therefore it can be concluded that SCNT foetuses largely undergo reprogramming, but the 
epigenetic signature at this stage cannot predict whether the foetus will develop to term or not. 
Longevity and reproductive physiology of cattle clones 
Ten SCNT clones when bred with conventional bulls have given birth to 3 calves each per year (i.e. 30 
offspring in total of which 2 calves were stillborn) and they all exhibited normal fertility and 
productivity parameters (Miyashita et al., 2011). 
Male clones (bulls) had semen DNA methylation patterns within the normal range and normal DNA 
methylation patterns were also reported in their offspring (Couldrey et al., 2011). 
Four groups of clones from different breeds (18 clones in total), were artificially inseminated after 
reaching the breeding age and breeding was repeated until the third, fourth or sixth parity, depending 
on the breed. Taking into account disease/injury/accident-associated damages, the survival time and 
mean parity of the clones was found favourable when compared to the control group (Konishi et al., 
2011).  
 
Pigs: 
In some cases, weights at birth of surviving clones were found to be higher than conventional animals 
(Martinez-Diaz et al., 2010; Schmidt et al., 2010; Watanabe, 2011) but others have reported the 
opposite (Estrada et al., 2007; Vajta et al., 2007). However, weight at birth is critically dependent upon 
litter size; small litters will result in higher individual birth weights, irrespective of the production 
method. Researchers, having produced >400 transgenic clones of pigs, did not observe oversized 
piglets in litters with normal size (Niemann et al. (2012), oral communication).  
In another study, total perinatal mortality for two pig breeds was 49% although it was lower in LWs 
(34%) compared with minipigs (56%) but still higher than in conventional pigs (10-15%) (Schmidt et 
al., 2010). Watanabe (2011) also reported on neonatal deaths, which were seen more frequently in 
SCNT clones than in their progeny (8.9 vs 1.4%), and post-perinatal losses due to disease were 27.7% 
for SCNT vs 11.9% for progeny of clones. These figures for clone progeny were very similar to 
independent data for conventional animals as reported by the National Animal Disease Information 
Service (NADIS)
7, (2011). 
                                                      
7 http://www.nadis.org.uk/ 2012 Update on cloning of farmed animals
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The percentage of SCNT piglets born with malformations was higher than in normal animals: 7% for 
LW clones and 26% for minipig clones. The piglets were killed when they were malformed for 
example in their legs, heart, diaphragm, tongue or testes, or when they did not function normally and 
had for example anorexia or no weight gain (Schmidt et al., 2010). At post-mortem examinations the 
organ weights of the heart, small intestine and kidney were lower than in conventionally bred piglets, 
whereas the weight of the pancreas was higher, and liver weight was borderline (p = 0.057) (Schmidt 
et al., 2011). In another report, haematology and clinical chemistry of surviving clones appeared 
normal (Watanabe, 2011).  
 
Longevity and reproductive physiology of pig clones 
Schmidt et al. (2010) reporting 39 SCNT surviving clones that have been kept in standard farmed 
conditions and killed occasionally for experimental purposes, found that all lived and none died 
naturally (one pig was 3 years old). During their lifetime none of the clones showed abnormalities in 
growth, behaviour or disease incidence. Nine 1 year-old male clones exhibited normal semen 
parameters; and when male and female clones were bred with conventional animals, their fertility 
appeared normal (Schmidt et al., 2010). 
Further to the fertility of pig clones, Liu et al. (2010) bred one male clone with conventional females 
to produce 98 (93 surviving) F1 offspring. They then outbred 3 of these F1 pigs to produce 22 F2 
piglets in 3 litters of which 14 piglets survived (one pig gave birth to 8 dead piglets accidently, which 
is also common in naturally bred groups). None of these breedings was outside normal reproduction 
parameters (given the small numbers involved). 
6.3.  Health and welfare of offspring of clones 
Adverse effects of cloning due to incomplete reprogramming were shown to result in difficult birth 
and health problems for a proportion of the surrogate dams and premature mortality of a proportion of 
the clones; these phenomena were shown to vary between species. However, neither of these 
phenomena appears to affect the offspring of clones, born through conventional breeding techniques.  
 
Offspring of cattle clones 
For cattle this was further supported by the above-mentioned report of Couldrey et al. (2011) who 
analysed the sperm DNA methylation patterns in ten genomic regions of 3 eighteen-month-old 
Friesian bull clones. There are very low levels of variation between the DNA methylation patterns 
from sperm of conventionally bred males even of different genetic background. Equally so, no 
differences were observed between sperm from the 3 bull clones and respective controls. This 
provides evidence that the donor cell genome is correctly reprogrammed upon passage through the 
germ line in males.  
 
Miyashita et al. (2011) found no differences in telomere length in 30 offspring from cattle clones when 
inseminated with semen from conventional bulls and their zootechnical performance was normal. 
 
Offspring of pig clones  
 
Liu et al. (2010) mated a male Guangxi Bama minipig clone produced from testicular fibroblast cells 
with 13 conventional sows to produce 93 offspring; all appeared healthy. Farrowing rate, litter size, 
and piglet survival were no different from controls. To evaluate the fertility of the clones’ offspring, 
the authors also produced 14 F2 normal piglets from three F1 females: three F1 female pigs from the 
cloned minipig were artificially inseminated with semen from conventional Duroc or Landrace sires, 
giving rise to 22 piglets, of which in the 3 litters: 13 piglets were born alive, 1 born alive, and in the 
third litter all 8 were dead; all 14 survivors appeared healthy. 
Watanabe (2011) found that stillbirths and neonatal deaths in the offspring of SCNT clones were 5.6% 
and 1.4% respectively. All of these piglets were delivered by natural parturition and the birth weight 
from piglets surviving the perinatal period were similar to that from conventionally bred piglets.   
 2012 Update on cloning of farmed animals
 
EFSA Journal 2012;10(7):2794  14
As previously reported, there are no indications found for health and welfare concerns of offspring of 
cattle or pig clones.  
 
Recloning 
 
Recloning is using a somatic cell of an animal clone to make a new clone. Wang et al. (2011) extended 
the work of Kubota et al. who had already shown in 2004 that second-generation clones (C2), 
generated from a somatic nucleus of a first-generation donor clone (C1) could be healthy and of 
normal fertility. Wang et al. (2011) evaluated the cloning efficiency of second-generation cloning of 
Holstein cow clones derived from ear fibroblasts of a first-generation cow clone, and assessed their 
health status in terms of physical, growth and reproductive parameters. After embryo transfer, both 
pregnancy rate to term and calving rate of C2 cloning were approximately half of C1 cloning (5.8% 
vs. 10.7%; 3.9% vs. 8.6%, p > 0.05). Six C2 clones were delivered, and three of them survived. These 
C2 clones displayed signs of being overweight at birth and tachycardia in the first week after birth. In 
summary, the results showed that although cloning efficiency of C2 was lower than that of C1, the 
surviving C2 (3 out of 6 died) clones appeared physically healthy and were fertile.  
6.4.  Conclusions on health and welfare of surrogate dams, clones and their offspring 
Although there have been many attempts to improve cloning techniques, no major changes have been 
reported that reflect positively on the compromised health and welfare of a proportion of the surrogate 
dams and of a proportion of the cattle and pig clones themselves. Although guidance
8 (IETS-HASAC, 
2008) has been published for veterinary practitioners to check the health and welfare and management 
of animals involved in cloning, there are few detailed whole animal reports published with a broad 
range of health measures
9. Rather the emphasis is on recording gross events such as survival, 
stillbirths, birth weights, malformations, and clinical chemistry and haematology. The use of more 
uniform criteria for checking the health status of surrogate dams and clones would be helpful.  
 
Those clones that survive often appear no different to conventional animals, although sample sizes and 
numbers of animals involved may often not be large enough to make robust conclusions, particularly 
for less frequent adverse events. Using a uniform and broader range of criteria combined with meta-
analyses would increase sample sizes, as was achieved through a nation wide survey of bovine clones 
in Japan (Watanabe, 2011). This would also be helpful for other species of clones and/or for other 
regions. 
With regard to the health and welfare of the progeny from breeding clones with conventional animals 
no health problems have been reported. 
 
                                                      
8  «  Health Assessment and Care for Animals Involved in the Cloning Process. A consensus recommendation from the 
International Embryo Transfer Society », 15 May 2008, elaborated by the IETS Health And Sanitary Advisory Committee 
(HASAC) and approved by the Board of Governors of this scientific society (incl. scientists and practitioners). 
9 Checking the health status should comprise aspects and measurements as advised by formal or acknowledged experts in 
the relevant clinical specialities, for example, inter alia, (1) Clinical examination and associated laboratory tests; (2) 
Zootechnical data (e.g. normal development, feed intake, growth rate, fertility, feed conversion rate, productivity indices); (3) 
Measurements of relevant aspects of physiology, such as immune function (e.g. immunological challenge with antigens 
producing B-cell or T-cell responses, temperature tolerance); and (4) Health records, for example, evidence of the results of 
post-mortem and associated laboratory examinations of all animals found sick or dead in order to identify the cause of death; 
post-mortem examination of all animals slaughtered or euthanised at the end of the experiments; and incidence of body 
injuries, body malfunctions and disease (infectious and non-infectious), and medicine use, should all be taken into account. 
Checking the welfare should address the ability of the animals to carry out normal behaviour, physiological functions and to 
develop normally. Abnormal behaviours may relate to feeding, locomotion, social behaviour (e.g. aggression), and other 
responsiveness measures, such as flight distances. The occurrence of stereotypies, the extent to which strongly preferred 
behaviours can be shown, and the extent of any avoidance behaviours should be recorded (e.g. filming animals). For cattle 
and pigs, more detailed parameters have been described in Appendix 3 of EFSA 2012a (Scientific Opinion of AHAW Panel: 
Scientific Opinion on the use of animal-based measures to assess welfare of dairy cows   
www.efsa.europa.eu/en/efsajournal/pub/2554.htm) and in Appendix 2 of EFSA 2012b (Scientific Opinion of AHAW Panel: 
Scientific Opinion on the use of animal-based measures to assess welfare in pigs   
www.efsa.europa.eu/en/efsajournal/pub/2512.htm), respectively.  2012 Update on cloning of farmed animals
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7.  SAFETY OF MILK AND MEAT DERIVED FROM ANIMAL CLONES OR THEIR PROGENY  
The scientific assessment to address the safety of food/feed products from clones requires the 
availability of a variety of data on food/feed products from animal clones and their offspring including 
those obtained through analytical and nutritional investigations as well as toxicity testing dealing with 
many different end points. 
7.1.  Compositional data 
Several studies on the composition of bovine milk and meat and of pig meat, including water, fat, 
protein and carbohydrate content, amounts and distribution of amino acids, fatty acids, vitamins and 
minerals, were reviewed by the EFSA’s Scientific Committee (EFSA, 2008) without identifying any 
differences outside the normal (physiological) variability between clones (F0) or clone progeny (F1), 
and their comparators. 
 
In a study reported by Ito and Watanabe (2011), meat was derived from three progeny (F1) of 
conventional cows inseminated with semen from an SCNT bull and the milk from three progeny (F1) 
of cow clones (F0) inseminated with semen from a conventionally produced bull. Both these meat and 
milk were compared with the corresponding products from conventionally bred cattle. No significant 
differences in any components, including water content, ash content, cholesterol, calcium, amino 
acids, fatty acids and vitamins, were observed as depending on the origin of the milk or meat. 
 
In the report by Watanabe (2011) three of each ECNT cows, SCNT cows and conventionally bred 
cows were employed for producing milk, whereas one ECNT steer, one SCNT steer and three 
conventionally bred steers were fattened for meat production. Three of each progeny of SCNT cows 
and conventionally bred cows were employed for producing milk and three of each progeny (heifer) of 
SCNT cattle and conventionally bred heifers were fattened for producing meat. Normal compositions 
for a variety of parameters were determined in milk and meat from animal clones and their progeny. 
Some individual variations were observed, but they were not related to cloning. 
 
Moreover, the use of SCNT cattle and their progeny to evaluate milk and meat productive 
performance in comparison with conventionally bred cattle was reported by Watanabe (2011). The 
parameters investigated included, for milk, milk yield, lactation curves and a variety of quality 
indicators such as total fat, total protein and somatic cell counts, whereas, for meat, they included body 
weight gain, carcass traits and physiological properties. Only variations within the normal range were 
detected in this study. 
 
Changes in sensory (taste) traits of longissimus muscle (LM) were investigated using SCNT clones of 
Japanese black steers slaughtered at different ages (20, 25 and 30 months) and analysed jointly with 
fat content, soluble collagen content and collagen solubility (Okumura et al., 2012). Although this 
investigation was not performed comparatively with muscle from conventionally bred animals, the 
results reported did not point out any major peculiarity possibly associated with cloning. 
7.2.  Protein digestion rate 
Data on protein digestion rates were obtained from rats fed with milk/meat derived from 
conventionally bred cattle and progeny of SCNT cattle. The digestion rates of milk were 88.8% for 
that from conventionally bred cattle and 86.8% for that from the progeny of SCNT cattle. With regard 
to meat, the digestion rates were 90.3% for conventionally bred cattle and 89.5% for the progeny of 
cattle clones. Therefore, no significant differences in digestibility due to the origin of milk or meat 
were reported (Ito and Watanabe, 2011). Similar results were also described by Watanabe (2011) for 
milk/meat derived from the ECNT/ SCNT cattle clones as well as from the progeny of SCNT clones. 
7.3.  Allergenicity 
The 2008 EFSA Scientific Opinion reviewed the studies by Takahashi and Ito (2004) and by Heyman 
et al. (2007) showing the absence of any statistically significant difference in the allergenic potential 2012 Update on cloning of farmed animals
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observed in the rat between meat and milk from clones and from comparator control cattle. 
 
The mouse abdominal wall method was also applied more recently by sensitizing test mice through 
intra-peritoneal injection of the water (saline) soluble fraction of milk/meat powders derived from the 
ECNT/SCNT cattle or the progeny of cattle clones and from conventionally bred cattle; 14 days after 
sensitization, the mouse abdominal wall was exposed under anaesthesia and the elicitation solution 
was injected into the abdominal wall. No significant differences in anaphylactic reactions due to the 
origin of milk/meat were detected (Ito and Watanabe, 2011; Watanabe, 2011). It is though well 
known, that these results are only indicative as the rat and mouse models are not specific for human 
allergenicity predictive testing (WHO/FAO, 2001). 
7.4.  Genotoxicity 
As already reported in the 2008 EFSA Scientific Opinion on animal cloning derived by SCNT, 
Takahashi and Ito (2004) did not show any genotoxic potential in the meat derived from cattle clones 
tested using the mammalian erythrocytes micronucleus test. 
 
Data on the genotoxic potential of milk/meat powders derived from the ECNT/SCNT cattle clones or 
from the progeny of SCNT cattle and conventionally bred cattle were recently reported by Ito and 
Watanabe (2011) and Watanabe (2011). The micronucleus test was used to assess potential 
genotoxicity. Mice were fed for 14 days with test diets supplemented with milk powder derived from 
progeny of cattle clones or from the ECNT/SCNT cattle at 2 or 10% (w/w) and the incidence of 
micronucleated red blood cells was assessed. No significant differences were observed compared to 
the control groups. In addition, polychromatic cell rate as a proportion of total erythrocytes was not 
significantly different from the value observed in the control groups. Moreover, mutagenicity of meat 
powders derived from progeny and conventionally bred cattle or from the ECNT/SCNT cattle were 
investigated in mice. In the test diet supplemented with meat powder at 1 or 5% (w/w), the incidence 
of micronucleated cells was not significantly different compared to the control group. The authors 
concluded that milk/meat derived from progeny of cattle clones did not show any mutagenic potential. 
 
The results of in vitro (bacterial mutation and chromosome aberration) and in vivo (micronucleus) 
genotoxicity studies of SCNT cattle meat were published by Lee et al. (2011). Several concentrations 
of meat extracts from both conventional cattle and clones, were tested in five strains of bacteria 
(Salmonella typhimurium: TA98, TA100, TA1535, and TA1537; Escherichia coli: WP2uvrA) for 
bacterial mutation and to Chinese hamster lung (CHL/IU) cells for chromosome aberration, 
respectively. For the micronucleus test, mice were divided into five dietary groups: commercial pellets 
(control), pellets containing 5% and 10% conventional cattle meat, and pellets containing 5% and 10% 
meat from cattle clones. No test substance-related genotoxicity was noted in the five bacterial strains, 
CHL/IU cells, or mouse bone marrow cells. 
7.5.  Toxicity and reproduction studies  
Results of 14-week feeding studies in rats given a diet of milk or meat from ECNT/SCNT cattle in 
comparison with milk and meat from conventionally bred cattle have been reported by Yamaguchi et 
al. (2007) and Watanabe (2011) with the conclusions that physiological conditions of the test animals 
had not been affected by any treatment. 
 
Watanabe (2011) also reported the results of a 12-month feeding study in rats given a diet of milk or 
meat from progeny of SCNT cattle clones and conventionally bred animals. In this study, in addition 
to the parameters commonly determined to assess the health status of test and control animals, 
additional observations focussed on reproduction of dams and the health status of their pups. No 
biologically relevant indication emerged from this study that milk or meat from cattle clones was 
different from control products. 
 
Yamaguchi et al. (2008) and Ito and Watanabe (2011) have reported results obtained through 12-
month feeding studies with rat groups given a diet supplemented with the milk/meat powder from 2012 Update on cloning of farmed animals
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progeny of somatic cell nuclear transfer clones or from corresponding products from conventionally 
bred animals. The rats were subjected to clinical observations of general health conditions. Moreover, 
sexually mature rats fed the test diets were mated and examined for indices such as the reproductive 
performances of the dams and health of their pups, without detecting any biologically relevant 
differences. 
 
Furthermore, two reproduction toxicity studies, one in rats and the other in rabbits fed meat from cattle 
clones, were previously reviewed in the 2010 EFSA Statement on cloning. No biologically relevant 
differences associated with cloning were detected for the reproductive parameters. 
 
The effects on the behavioural and reproductive characteristics of F1 rats derived from dams fed 
during pregnancy a diet supplemented with SCNT cattle meat were investigated by Yang et al. (2011). 
F1 rats were divided into five diet groups with their dams: commercial pellets (control), pellets 
containing 5% (N-5) and 10% (N-10) of conventional-cattle meat, and diets containing 5% (C-5) and 
10% (C-10) of clone meat. In most cases, the cloned-cattle meat diet did not affect body weight and 
food consumption in male and female F1 rats during 11 weeks. However, the authors found 
significantly higher main body weight of males in N-5 (at 3 weeks), males in N-10 (at 3 and 5 weeks), 
and females in N-10 at 4 weeks. Rates of food consumption of males was significantly higher in the 
meat-diet groups (conventional- and cloned-cattle meat at 7 to 9 weeks), as compared with the 
controls, but not for females.  No signs of test substance-related toxicities were detected on organ 
weights and behavioural characteristics (sensory reflex, motor function, and spatial learning and 
memory tests). Reproductive functions (mating, fertility, and implantation) did not significantly differ 
among all examined rats. 
 
EFSA notes that not many publications have appeared on long-term toxicity studies of food products 
from animal clones over the last 2 years. It is understood that researchers might not be inclined to 
undertake such studies which are unlikely to indicate any significant differences associated with the 
use of SCNT cloning. Further, not all countries regard whole food feeding studies as providing 
required information. 
7.6.  Conclusion of meat and milk of clones and progeny 
Since the publication of the EFSA 2010 Statement, several recent research results have become 
available dealing with genotoxicity and reproduction toxicity of milk and meat from SCNT cattle 
clones and their progeny. These recently published data, do not affect in any way the conclusion 
reached in the previous EFSA risk assessments and confirm that there are no indications that 
differences exist in terms of composition and food safety between food products from healthy cattle 
and pig clones and their progeny, compared with those from healthy conventionally bred animals. 
Moreover, data on clones of farmed species for food production other than cattle and pigs have 
remained limited and do not allow for the assessment of food safety or animal health and welfare 
aspects. 
8.  ENVIRONMENTAL IMPACT OF CLONING OF FARMED ANIMALS 
No new elements have emerged that would change previous EFSA Scientific Opinions: i.e. cloning in 
itself of farmed animals poses no particular threats for genetic diversity or biodiversity
10; and from the 
limited data available there are no indications that would suggest new or additional environmental 
risks from cloning farmed animals when compared to conventionally bred farmed animals. There is 
also no information available to suggest that such risk may exist. 
                                                      
10 Biodiversity and genetic diversity are important protection goals in the EU  : 
http://ec.europa.eu/environment/nature/biodiversity/comm2006/pdf/2020/1_EN_ACT_part1_v7[1].pdf 
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OVERALL CONCLUSIONS  
The previous EFSA conclusions (EFSA, 2008, 2009, 2010) are confirmed on the basis of the review of 
the recent scientific literature and other information made available to EFSA. 
•  With respect to food safety, there are no indications that differences exist between products (i.e. 
meat and milk) of healthy clones or their offspring when compared with those from healthy 
conventionally bred animals. 
•  SCNT can produce healthy clones, but during the SCNT cloning process, animal health and 
welfare remains a matter of concern mainly due to mortality at all developmental stages (from 
the perinatal period until the juvenile stage, as well as mortality through abortion), which is 
higher than for other ARTs with in vitro produced embryos. Importantly however, there are no 
indications found for health and welfare concerns for offspring of clones born through 
conventional breeding. 
•  For cloning of farmed animals as such, there is no new scientific information that would suggest 
risk to genetic diversity, biodiversity or the environment, when compared to conventionally bred 
farmed animals. 
•  Data on clones of farmed species for food production other than cattle and pigs have remained 
limited and do not allow for assessment of food safety or animal health and welfare aspects. 
Large sample sizes that would allow more robust conclusions are also often not available. 
•  Continued research with farmed animals for the optimisation of the different steps of SCNT 
cloning has resulted in increased knowledge on the basic biological processes involved. Limited 
improvements were shown by some researchers, but so far have not led to a breakthrough for the 
overall cloning efficiency.  
Furthermore it is considered that 
•  A harmonised framework to report any additional data on cloning efficiency would be helpful to 
have a normalized set for appropriate comparisons, if and when more data would be generated. 
•  A harmonised framework and a uniform set of species-specific parameters to report on health 
and welfare of clones in a more consistent manner would be helpful, if and when more data 
would be generated in the future. 2012 Update on cloning of farmed animals
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DOCUMENTATION TO THIS EFSA STATEMENT 
In order to answer the Terms of Reference, EFSA collected information as follows.  
 
Literature search 
From the background information, the previous EFSA work on cloning and the Terms of Reference, 
EFSA has identified the issues to be addressed in the present Statement. On 15 March 2012 the 
databases of ISI Web of Knowledge were searched with the search conditions as shown in Table 2, 
yielding 548 records. The search protocol was based on the one used for the EFSA 2009 and 2010 
Statements; and was updated with the assistance of an information specialist of the EFSA SAS Unit. 
Screening 
The records were screened by the titles and the abstracts. Those that were considered for this 
Statement focus on food producing animals (e.g. mainly cattle and pigs), epigenetics, longevity, 
clones, clone progeny, animal welfare, health, toxicity tests, risk assessment etc. The following 
records were not considered: papers on molecular cloning of genetic constructs; duplicates; meetings 
records (unless of particular importance); transgenic animals and their cloning for medical research
11; 
inter-species cloning; most reports on cloning of non-food/feed animals (e.g. mouse, rats); and papers 
from 2010 that were already cited in the EFSA 2010 Statement. The above eligibility criteria are 
essentially the same as for the 2009 and 2010 EFSA Statements and yielded approximately 90 papers 
that were studied in further detail. Key papers that are most relevant are reflected in this Statement. 
Table 2:   Search limitations as used on 15 March 2012 on the ISI Web of Knowledge.  
Limitations
 
Boolean operator    AND  AND 
Search terms  Topic=(clon*)   Topic=(“nucl* 
transfer”)  
Topic=(Animal OR embryo OR neonate OR 
placent* OR endometr* OR donor cell OR 
blastocyte OR Cow OR Cows OR Cattle OR 
Bovine OR Calf OR Calves OR Bull OR Bulls 
OR Bullock$ OR Heifer$ OR Livestock OR Pig$ 
OR porcine OR piglet$ OR Sow OR Bore OR 
Sheep OR Ovine OR lamb OR Goat OR Rabbit 
OR Horse OR foal OR mare OR Fish OR 
Chicken OR bird$)  
Language  = English      
Timespan  = 2010-2012      
Lemmatization  = on      
(* and $):  are truncations  
 
Open call for data 
As for the 2009 and 2010 EFSA Statements, a call for data was published on the EFSA website for 1 
month (i.e. from 17 February to 17 March 2012). This call for data was further disseminated through 
existing networks such as the EFSA Advisory forum and focal points; the International Food Chemical 
Safety Liaison group (IFCSLG) that includes other international risk assessment agencies (notably 
from the US (FDA), UK (FSA), CA, NZ, AU, FR (ANSES) and JP); the European Commission 
services; and through targeted e-mails to cloning experts from cloning companies, EU research groups 
and organisations who previously contributed to EFSA’s work on cloning. 
During the call for data the following information, some unpublished, was received: 
1.  Individual scientist based in UK. 1 publication. 
2.  Individual scientist based in Italy. 1 paper accepted for publication. 
                                                      
11 EFSA notes that most pig clones are transgenic and developed for medicinal research. 2012 Update on cloning of farmed animals
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3.  Individual scientist based in USA. 1 draft paper. 
4.  Breed society based in UK. E-mail, 1 page; a Policy position paper in relation to registration of 
the progeny from clones. 
5.  Individual scientist based in France. Two papers; a list of abstracts published in the proceeding 
of the International Embryo Transfer Society (IETS) annual meeting 2011; a poster presented at 
the same annual meeting; a PhD thesis defended in November 2011. 
6.  FDA liaison officer to EFSA. A list of 57 publications related to animal cloning. 
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APPENDIX 1:  
CHANGES TO CLONING PROTOCOLS FOR FARMED ANIMALS OVER THE LAST 2 YEARS 
The state-of-the art technical steps and the best practice in the classical cloning procedures for 
bovine or porcine SCNT were described recently by Niemann et al. (2011).  
Aspects that influence the efficiency of cloning, as reported by EFSA in 2008, 2009 and 2010, 
include the handling of somatic nucleus donor cells and recipient enucleated oocytes (ooplasms) at 
embryo reconstruction, description of nuclear remodelling, in vitro culture conditions of early 
developing embryos and analysis of genomic reprogramming in relation to epigenetic modification 
occurring in the genome, gene expression in the placenta and at foetal stages, and physiological 
features of cloned calves. Substantial numbers of studies on these aspects have been performed and 
recent records are reviewed below. They reflect the remarkable efforts of the scientific community to 
try to overcome impeding factors for the efficiency of cloning in farmed animals. A priority is given 
below to studies based on the in vivo development of SCNT-derived embryos at the level of the foetus, 
neonate or live clone. Reports limited to the in vitro development of embryos to the blastocyst stage 
are also considered but only when of particular relevance for complementary scientific information to 
the in vivo achievements. Whenever possible, improvement in cloning efficiency has been evaluated 
by comparison with the development of non-cloned embryo obtained by the conventional techniques 
of in vitro fertilization (IVF) or artificial insemination (AI). 
The main picture that emerges from the literature published between 2010 and 2012 on farmed animal 
cloning is that progress in terms of cloning efficiency remains modest. Cattle and pig are the two 
leading species in terms of numbers of published papers and propositions for improving technical 
protocols, which differ between the two species. However, several advances in efficiency gain 
obtained during the same period but in the mouse academic animal model - where some potentially 
controllable reprogramming errors have been identified - may be expected to steadily lead to 
improvements per species. These future developments are briefly presented herein as a conclusion to 
the improvement of the cloning protocol for farmed animals.  
  A.1 Update on the contribution of farmed animals to the scientific understanding of 
cloning 
 
•  Epigenetic reprogramming  
Data published over the past two years have confirmed that demethylation of the DNA of donor cell 
genome occurs rapidly after SCNT but with differences between species and more importantly 
between SCNT embryos obtained from the same batch of donor cells. This was clearly shown during 
in vitro culture of cattle embryos by Sawai et al. (2011) in a comparative analysis of DNA methylation 
in individual blastocysts obtained eight days after SCNT, or in vitro fertilisation, or parthenogenetic 
activation, or embryonic cell nuclear transfer (ECNT), or in vivo (artificial insemination). Using the 
bisulfite method to measure the methylation level of cytosines within the satellite 1 region of bovine 
genome (a DNA repeated sequence with highly conserved motifs amendable to methylation (the CpG 
motifs)) the authors found that the DNA of SCNT blastocysts although less methylated than the DNA 
of donor cells remained about twice as more methylated than in non-cloned embryos. Marked 
individual variations were however observed within a given batch of blastocysts obtained from the 
same donor cells (40 to 60% of methylated sites). This variability was higher than between the three 
batches of blastocysts generated from three different donor cells. However, in vitro development to the 
blastocyst stage was similar in SCNT (21.9% from 183 one-cell stage embryos) and in vitro fertilised 
embryos (21.1% from 142 one-cell stage embryos). Moreover, full-term development efficiencies 
between three different cell donors were not different. Thus, changes in the DNA methylation level of 
SCNT pre-implantation blastocysts in vitro, although they reflect some degree of reprogramming of 
somatic nuclei, appear to be a poor marker of the further in vivo developmental potential in cattle. 2012 Update on cloning of farmed animals
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The same group provided also evidence that DNA methylation of the same target DNA sequence 
could be in fact spontaneously corrected in vivo during the elongation period that precedes 
implantation (Sawai et al., 2010) and after an initial period of in vitro development to the blastocyst 
stage. They evidenced a shift in methylation levels between day 8 (transfer of blastocysts to recipient) 
and day 16 when the still non-implanted but elongated embryos were recovered. Aberrant methylation 
level of bovine SCNT embryos at day 8 (hypermethylation) were found to be normal at day 16 when 
the methylation status of satellite 1 sequence became no more significantly different than in in vivo 
produced embryos. Quantification by real time PCR analysis of the level of DNA (cytosine-5-)-
methyltransferase 1 (Dnmt1) expression in SCNT and in vivo produced embryos provides evidence 
that the adjustment of DNA methylation levels was the result of demethylation and retention of 
methylation processes. The above data illustrate the advantage of the long gestation period of 
farmed mammals (much longer than in rodents) to provide insights into the time-dependent epigenetic 
modifications (here DNA methylation and Dnmt1 activity) that can contribute to the adjustment of the 
gene expression levels expressed by a developing reprogrammed genome.  
 
•  Epigenetic alterations and (ab)normal phenotype 
In the pig, tissue-specific differences with respect to both gene expression and DNA methylation were 
analysed in muscle as well as in liver of two SCNT and two control 6-weeks old male piglets (Gao et 
al., 2011). While gene expression profiles were generally found to be similar for each tissue between 
SCNT and controls, the pattern of DNA methylation was more different than the gene expression 
pattern. This was true for the non-repeated sequences as well as for repeated sequences. 
On the contrary, Park et al. (2011) found that gene expression patterns of five one-month old pig 
clones (males and females) of normal phenotypically appearance and generated from foetal fibroblast 
is altered when compared to controls of the same age (but with different genotypes). The 13K 
oligonucleotide micro array used by the authors reveals less variability of the global gene expression 
profiles in the brain, kidney and lung tissues between piglet clones than between controls as would be 
expected. Several differentially dysregultated genes of clinical relevance were found to be associated 
with histological evidences of some altered lung function (collapsed alevaoli). As for cattle, pig 
clones were found generally hypermethylated. The above observations confirm that alterations in 
DNA methylation are still present in the genome of phenotypically normal clones. This remains 
an important issue in farmed animal cloning.  
 
•  Clones as epigenome variants 
In cattle, de Montera et al. (2010) showed by measuring the 5-methylcytosine (5mC) levels in 
leukocyte DNA of 38 adult female clones of two different breeds (Holstein and Simmenthal, 19 
animals for each breed) that healthy SCNT animals must be considered as epigenetic variants. The 
estimated variance in 5mC level within clone genotypes (2 to 7 animal per genotype for each breed) 
was higher than between clone genotypes. Quantification of the contribution of SCNT to this 
unexpected variability was done by comparing clones with monozygotic twins (14 pairs) of similar 
age and breed. The estimated variability between SCNT animals obtained from the same donor (same 
genotype) was again significantly higher than between SCNT animals obtained from different donor 
cells (different genotype). In contrast, twins showed lower variability within genotypes than between 
genotypes. The clone-specific variability in DNA methylation clearly show that healthy adult SCNT 
clones must be considered as epigenome variants. 
 
This conclusion is also supported by the work of Takeda et al. (2011) who compared the variations in 
mitochondrial protein levels between SCNT derived and AI derived adult cattle and calves. Using 
the classical 2D gel electrophoresis that allowed the simultaneous detection of 1500 protein spots from 
one sample, the authors detected several marked difference in the level of expression (up to 5.5-fold 
up regulation or 3-fold down regulation) of more than 20 protein spots between three adult SCNT 
females obtained from the same donor cell line and of the same age. No evidence of mitochondrial 
heteroplasmy (originating from their recipient oocyte at SCNT) could be detected between the 
genomes of these females. Conversely, the authors could not detect any differences in the pattern of 
protein synthesis between two adult female clones of the same age (6 years), obtained from the same 2012 Update on cloning of farmed animals
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batch of donor cells, but with evidence of mitochondrial heteroplasmy. Thus mtDNA heteroplasmy 
inherited after nuclear transfer is not the cause of variation in mitochondrial gene expression 
observed between adult clones. The authors also found that the liver of all non-viable neonatal SCNT 
calves overexpressed (by a factor 2) the 78kD glucose regulated protein precursor and the protein 
disulfite isomerase A3 precursor, both of mitochondrial origin. This result implicates mitochondrial-
related gene expression in developmental losses of SCNT embryos.  
  A.2 Handling of donor cells and ooplasms at embryo reconstruction and activation 
 
Under the hypothesis that alterations frequently associated with SCNT stem from the initial 
remodelling of the somatic nucleus and/or from the early reprogramming of genes that control the first 
steps of development, several attempts were made to modulate the remodelling and early 
reprogramming events of the somatic nuclei by modifying their micro-environments when in culture 
to determine whether it is possible to increase the yield of blastocysts and the efficiency of cloning. 
The main improvements for the production of transferable SCNT embryos, obtained from 
modification of the embryo micro-environment and culture conditions, are listed below. 
 
Hand-made cloning (HMC) is a technique initially proposed by Vajta et al. (2003) to facilitate the 
application of cloning in farmed animals. This technique has the feature of removal of the zona 
pellucida prior to enucleation and fusion, resulting in a limited (or no) requirement for 
micromanipulators. The benefits of HMC are low equipment costs, simplification of the manipulations 
and time reduction of the cloning process. Over the past two years, reports have been published on the 
birth of live animals obtained after HMC (Buffalo: Panda et al. (2012); Cattle: Akagi et al. (2011); 
Pig: (Clausen et al., 2011; Schmidt et al., 2010; Schmidt et al., 2011; Staunstrup et al., 2012), and 
several reports described in vitro increase in the rate of blastocysts obtained compared with the 
traditional SCNT (e.g. for pigs: Zhang et al. (2011)). Further technical improvements, including the 
possibility of partial or full automation of somatic cell nuclear transfer (Vajta and Callesen, 2012), 
could contribute to facilitate working with this technique. 
 
The duration of exposure of the somatic nucleus to ooplasm factors before induction of the activation 
process that initiates development, and the activation process itself are critical steps of any cloning 
procedure. These steps were investigated by several research groups (see paragraphs below), however, 
no major advances were reported over the last 2 years for improving the overall cloning procedure. 
By controlling the usage of the cell-cycle inhibitor Butyrolactone I to allow a time extension for the 
manipulation of batches of oocytes, De Bem et al. (2011) could obtain the birth of live calves but 
with an efficiency of only 7.7%. A similar strategy obtained by preventing the degradation of cyclin B 
with MG132, an inhibitor of the proteasomal machinery formerly used in rat cloning experiments, was 
adapted to cattle by Le Bourhis et al. (2010): an exposure of oocytes for 45 to 90 minutes during 
enucleation and up to electrofusion of the donor somatic cell resulted in a significant increase of cells 
at the blastocyst stage in comparison to controls (about 25%) and a higher rate of pregnancy at day 35, 
although no clear conclusion could be drawn in this study because of the reduced number of recipients 
used (n=4 only). Similar beneficial effect of MG132 exposure of recipient pig oocytes during the long 
period of maturation required in vitro before manipulation (44h) in that species, was reported by You 
et al. (2012) with an increase in the number of cells at the blastocyst stage of 25%. 
 
Limitation of the cellular stresses induced by fusion and activation conditions was also considered as 
beneficial to cloning efficiency and studies by several groups but with in vitro data only. Useful results 
were obtained in cattle by Song et al. (2011) who revisited the use of an inactivated viral envelope 
(Sendai virus, SV) as fusion material for the reconstruction of embryos. This technique had been 
initially proposed in the mouse in the very first staged of nuclear transfer research (Surani et al., 1984). 
Sendai virus mediated fusion was shown to reduce the transcription level of several endoplasmic 
reticulum stress-associated genes stimulated by electrofusion while it improved the number of 
blastomeres in SV-SCNT blastocysts by 35%; the ratio of inner cell mass cells to the total number of 
cells tended however to be lower than in control IVF or electrostimulated SCNT embryos.  
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Aggregation of SCNT embryos (by letting them fuse when locked in a small volume after 
manipulation) provides an epigenetic compensation between the three reprogrammed genomes (Boiani 
et al. (2003) in the mouse; Kurosaka et al. (2007) in cattle). Akagi et al. (2011) tested the timing of 
removal of the zona pellucida of the oocyte and the timing of aggregation of bovine SCNT embryos 
(i.e. at the 1-cell, at the 8-cell on day 2, and at the 16- to 32 cell stages on day 4). Full term 
pregnancies were obtained after aggregation of three SCNT embryos at the 8 cell stage (two calves 
from a total of 11 aggregates, one stillborn, the other healthy) or at the 16- to 32-cell stage (1 calf, but 
stillborn, generated from a total of 7 aggregates). Given this small number, it is unclear whether 
aggregation of three SCNT embryos had an influence on perinatal mortality. The overall efficiency 
expressed in terms of healthy calves/transferred embryo remained low (9%; 1 out of 11). 
The spatial organisation of chromatin is dramatically affected upon the entry of a somatic nucleus in 
a recipient cytoplasm. By studying the distribution of the heterochromatin protein CBX1, together 
with that of the centromeric proteins CENPA and CENPB and trimethylated histone H3, Pichugin et 
al. (2010) found that two contrasted types of SCNT embryos could be made distinguished in cattle at 
the 2- and 4-cell stages. They predicted that these two types of SCNT embryos will display different 
chromosome territory arrangements and proposed to use that nuclear organisation to screen for the 
technical conditions that improve epigenetic reprogramming. A similar suggestion was made by 
Deshmukh et al. (2012) for SCNT pig embryos which spatial distribution and dynamics of chromatin 
at the 2- and 4-cell stages display marked variations. They proposed that the lack of a heterochromatin 
halo around nucleolar precursor reveals altered chromatin remodelling. These promising and 
innovative approaches are to be confirmed with further results. 
 
In vivo data are considered as scientifically necessary before concluding on any improvement in the 
technique of nuclear transfer per se. This has been convincingly demonstrated by Whitworth et al. 
(2010) who compared three activation techniques for SCNT pig embryos, namely MG132 induced 
activation, electrofusion only, or exposure to Thimesoral, a sulfhydryl agent that stimulates the release 
of cytosolic free calcium. None of these techniques could prevent abnormal expression of placental 
genes at day 30 of gestation. 
 A.3  In vitro culture of developing embryos: nuclear remodelling and reprogramming  
 
Progresses in cellular imaging and high-throughput molecular analysis of DNA methylation and 
histone modifications stimulate an already active field of research including epigenetics, stem cell 
biology, reproductively biology, and veterinary sciences. In this context, SCNT-derived embryos of 
farmed animals are most often used to extend observations made in the mouse with the scope that 
altering the microenvironment of the embryos will lead to a more complete reprogramming and 
followed by improvements in SCNT efficiency. However, few papers provide an in vivo validation of 
observations made in vitro, mainly because of the costs of experiments with large farmed mammals. 
These papers have been given priority in the below paragraphs. 
 
•  Nuclear remodelling  
Mitosis is essential to make mammalian somatic nuclei prone to reprogramming. Recent results 
obtained in the mouse (Ganier et al., 2011) have demonstrated that Xenopus mitotic egg extracts 
have a strong reprogramming activity on mouse somatic nuclei (cultured fibroblasts). The experiment 
reset replication properties of somatic nuclei towards a replication profile characteristic of early 
development resulting in a four time increase in the rate of blastocyst obtained in vitro from 2-cell 
stage treated SCNT embryos (45%) in comparison with non-treated ones (11%).  
This heterologous Xenopus extract was also applied to sheep SCNT as pre-treatment of donor somatic 
cells. No increase in the frequency of development to blastocyst stage was observed with treated donor 
cells; however, live births were significantly more after the transfer of treated blastocysts with a 4.7-
fold increase in comparison with controls (non-treated embryos). The percentage of lambs surviving to 
adulthood of blastocysts transferred (5.9%) increased 1.9-fold compared to controls (Rathbone et al., 
2010).  2012 Update on cloning of farmed animals
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In the pig Liu et al. (2012) did observe an increase in the formation of blastocysts with cells exposed 
to Xenopus extracts and induced to reprogram in vitro for 7 to 8 days before being used as a source of 
nuclei for nuclear transfer. No in vivo data have yet been reported in that species. Xenopus egg 
extracts are known to abruptly erase epigenetic marks at mitosis such as trimethylation of H3K9, 
H3K4, and H4K20 but their biochemical activity and quality vary from batch to batch. This is a 
present limitation to a technique that could contribute to characterise the key molecular players of 
nucleus reprogramming that are well conserved between species. 
 
Inadequate spatio-temporal reorganization of the donor nucleus has been described with rabbit 
SCNT (Bonnet-Garnier et al., 2012). Since nuclear architecture is determinant in cell specialisation 
(Cremer and Zakhartchenko, 2011) spatio-temporal remodelling should be considered as an additional 
and more integrated level of SCNT alteration. In the pig Deshmukh et al. (2012) provided clear 
evidence that whatever the method used for generating embryos in vitro ( in vitro fertilisation, 
parthenogenetic activation or SCNT), the remodelling of chromatin is altered in comparison with in 
vivo produced embryos. Interestingly early SCNT one-cell stage embryos had high level of DNA 
methylation similar to somatic nuclei even though the structural remodelling to a pronuclear like 
structure occurred normally. At later stages SCNT blastocysts displayed high variations in methylation 
levels but some were similar to in vivo produced embryos. The remodelling events that affect higher 
order structure of chromatin are thus somewhat disconnected from the epigenetic modifications 
(methylation) that regulate the reprogramming of genome functions. 
 
•  Reprogramming of nuclear functions: DNA methylation and histone acetylation 
DNA methylation and histone acetylation are highly dynamic processes that have a determinant role in 
the organization of chromatin and the time-dependent control of gene expression which is at the basis 
of reprogramming.  
 
DNA methylation  
 
DNA methylation plays a major role in the reprogramming of somatic nuclear activities. This highly 
dynamic process controls the expression of genes critically involved in pluripotency and cell 
differentiation. During the pre-implantation period of development de novo DNA methylation occurs 
in a species-specific manner and can be affected by in vitro culture conditions. Numerous reports had 
attempted to improve the efficiency of early embryonic development of SCNT-derived embryos by 
altering the DNA methylation pattern of reprogrammed nuclei in vitro but with limited successes 
in terms of full reprogramming of genomic functions.  
By normalising the DNA methylation levels by the DNA content of pig embryos at different stages of 
their pre-implantation development, Deshmukh et al. (2011) confirmed the high level of DNA 
methylation in SCNT 1-cell stage embryos relative to in vivo produced ones. They found that the 
methylation level was even higher in in vitro fertilised embryos. DNA methylation pattern are thus 
affected by in vitro embryo production (and is not specific for SCNT). Interestingly, SCNT embryos 
displayed a pronounced variation in methylation level at the blastocyst stage but with respectively 
50% and 14% of them having similar levels to that of in vivo produced embryos at the early (days 5-6) 
and late (days 6-7) blastocyst stages. These results suggest that measuring the normalised DNA 
methylation contents of SCNT cultured and in vivo produced early and late blastocysts could to some 
extend allow an empirical mean for a multifactor improvement of culture conditions adapted to SCNT 
embryos. 
 
Histone acetylation 
 
Modifications to the histone acetylation pattern of donor cells or that of early SCNT embryos by their 
transient exposure to various drugs (such as deacetylase inhibitors) is an active research area in 
cloning. Many reports examined the proportion of SCNT embryos that develop to the blastocyst stage 
and consider the allocation of cells between the two first cell lineages that differentiate at that stage 
(the trophoblast and the inner cell mass cells). Only a few also examine the in vivo developmental 2012 Update on cloning of farmed animals
 
EFSA Journal 2012;10(7):2794  26
potential of such treated embryos. A variety of deacetylase inhibitors (HDACi) have been used by 
different research groups.  
 
Zhao et al. (2010) showed that an exposure of pig embryos to the histone deacetylases inhibitor 
Trichostatin A (TSA) (during 10h after activation) or Scriptaid (14-16h after activation) increases 
the percentage of blastocysts formed in culture at 144h by respectively a factor of 3.2 and 2 without 
affecting the blastocyst’s cell numbers. Exposure to Scriptaid not only improved the histone 
acetylation on Histone H4 at lysine 8 (AcH4K8) in a pattern similar to that of the in vitro fertilized 
(IVF) embryos but also increased the overall reprogramming efficiency of foetal fibroblasts cells from 
0.4% (untreated group, 211 embryos transferred to 2 recipients) to 1.6% (819 treated embryos 
transferred to 5 recipients). Similar positive effects of Sriptaid were reported in sheep SCNT by 
Bordignon et al. (2011) with a three time increase in the rate of initiated pregnancy (transfer of 178 1-
cell stage embryos to 8 recipients from which 4 became pregnant), in buffalo by Panda et al. (2012) 
with a 70% significant increase in blastocyst rate (54% versus 38% with controls) and a 100% increase 
in the number of cells per blastocyst (343 versus 150 for controls).  
 
Exposure of pig embryos to butyric acid for 4h immediately after activation (Das et al., 2010) 
improved the rate of blastocysts formed by a factor of 1.6 (18.3% vs 11.2%) without affecting the total 
number of cells. Histone acetylation levels became close to those in IVF embryos. There were no 
effects obtained when donor cells were treated for 24h before (instead of after) SCNT. This is a good 
indication that nuclear functions have in some manner been improved as a consequence of the action 
of the inhibitor during the early remodelling of the nucleus after SCNT.  
Exposure of cattle embryos to valproic acid (VPA) for 24h only marginally improved the 
development of bovine SCNT embryos at the blastocysts formed after, although it significantly 
reduced the rate of apoptosis (1.91±0.48% vs. 5.67±0.40%, p<0.05) (Xu et al., 2012). 
None of the above chromatin modifying agents, nor their combinations (e.g. (Azacytidine + TSA) or 
(Hydrazaline+VPA)) were found to have a positive effect in cattle when added on donor cell medium 
before SCNT (Sangalli et al., 2012). When (Hydrazaline+VPA) was added upon SCNT, the 
acetylation pattern of embryos was increased but without effect on development (both pre- and post-
implantation).  
•  Removal of animal protein source from the culture media. 
Avoidance of embryo contamination before their transfer in vivo into foster recipients is the objective 
of research that analyses the metabolite uptake and release by the embryo in its microenvironment. 
Chemically defined medium where Bovine Serum Albumin (BSA) or Foetal Bovine Serum (FBS) 
were replaced by the water-soluble polymer polyvinyl alcohol (PVA) associated with myo-inositola-
phosphate was shown by Jang et al. (2011) to lead to a higher rate of live calve clones (20% from 15 
blastocysts transferred into 7 recipients) than with the classical synthetic oviductal fluid (SOF) 
medium developed in the mouse but requiring a supplementation with BSA when used in cattle 
(11.9% only; 52 blastocysts transferred to 27 recipients). Interestingly, both media provided the same 
rate of blastocysts with a similar total number of cells. In both cases however cases of dystocia were 
observed. 
•  Mitochondria and oxidative stresses 
Oxydative stresses caused by a high intracellular oxygen concentration induced by in vitro culture 
have detrimental consequences on embryo development (Takahashi, 2012). Exposure of SCNT 
recipient pig oocytes to the anti-oxidative agent anthocyanin increases the rate of blastocyst formation 
by a factor of 2 (32.2% vs. 16.1%) while it has no effect during IVF. The quality of the blastocysts in 
terms of total number of cells is not affected (You et al., 2010). This confirms that prevention of 
Reactive Oxigen Species (ROS) is a positive factor for reprogramming.  
 
Oxydative stresses are linked to an increase in apoptosis that affects the kinetics of cell division in 
numerous cellular types. Taking this mechanism into account Jeon et al. (2011) propose the mRNA 
level of survivin, a member of the chromosomal passenger complex (CPC) with a bifunctional 
function on both the suppression of apoptosis and the regulation of cell cycle, as a new marker for 2012 Update on cloning of farmed animals
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embryo quality of in vitro developed pig embryos. They found that the kinetics of cleavage after the 
activation of SCNT eggs affects the rate of blastocysts obtained at day 7 with 2-cell embryos at 24h, 
leading to a significant higher rate of blastocysts when compared to less or more advanced SCNT 
embryos (18.0%, 376 embryos analysed with 6 replicate experiments). Level of survivin mRNA which 
parallels that of the protein, were also higher with this classified group suggesting that this class of 
early SCNT embryo had a higher developmental competence. No complementary in vivo data were 
however produced. 
 
Oxydative stresses provide a convenient, although limited read-out of the alterations that affect 
cellular metabolism. This implies a highly regulated process involving multiple signalling cascades. It 
is governed by mitochondrial activity which regulates the level of reactive oxygen species (ROS). To 
determine whether increasing the level of mitochondrial activity could lead to an improvement in 
SCNT embryo development, Hua et al. (2012) have used as donor nuclei foetal bovine fibroblasts with 
different expression levels of Mitofusin1 (Mfn1), the main mediator of mitochondrial homeostasis. 
Up-regulation or down regulation of the Mfn1 gene were obtained respectively from transgenic, of 
RNAi -treated donor cells. Results demonstrate that the up-regulation of Mfn1 expression improves 
the development rate of SCNT embryos to the blastocyst stage (by 40% when compared to control 
donor cells) while down-regulation of Mfn1 resulted in poor development (only 4.2% of blastocysts). 
This improvement resulted from an increase in both the ATP level and the mitochondrial membrane 
potential at the morula stage, while H2O2 generation was reduced. This indicated that overexpression 
of Mfn1 could promote the early development of bovine SCNT embryos by improving oxidative 
phosphorylation. 
 
That a transient modification of mitochondrial activity at the one-cell stage can exert late emerging 
developmental effects has been demonstrated recently in the mouse, but with normally fertilized 
mouse embryos. Indeed, Banrezes et al. (2011) have shown that stimulating or reducing mitochondrial 
activity by exposure of one-cell stage embryo (to respectively exogenous pyruvate or lactate) resulted 
in offspring with a permanent smaller or larger size. This result has however not yet been extended to 
SCNT. 
  A.4 Risk of disease transmission through cloning 
 
Bovine embryo transfer technology has been widely studied and a standard operating procedure for 
embryo production and transfer has been published by the International Embryo Transfer Society 
(IETS) (Stringfellow and Seidel, 1998) to ensure safety of this technology. Potential disease transfer 
was also taken into account in the guidance on Health Assessment and Care for Animals Involved in 
the Cloning Process (consensus recommendation from the International Embryo Transfer Society, 15 
May 2008, http://www.iets.org/comm_hasac.asp). Nonetheless, since oocytes used for somatic cell 
nuclear transfer embryo production are predominantly from abbatoirs and the nuclear transfer 
procedure produces small openings on the zona pellucida, the concern regarding potential disease 
transfer was further raised by Gregg et al. (2010a). An experimental risk assessment of bovine viral 
diarrhoea virus (BVDV) transmission via in vitro embryo production by SCNT published in 2009 
(Gregg et al.) focused on critical steps of the embryo production process for its risk of BVDV disease 
transmission (i.e. the donor somatic cell, the oocyte collected from commercial abbatoirs and the in 
vitro SCNT embryo culture system). This study made it possible to identify some key risk factors and 
to develop a SCNT standard operating procedure aiming at minimizing the risk for BVDV 
transmission through pre-nuclear transfer donor cell testing, oocyte decontamination and virus-free 
cell and embryos culture conditions. 
The large scale in vivo risk of transmitting viruses responsible for infectious diseases through SCNT-
derived embryos was further investigated for the BVDV by Gregg et al. (2009; 2010a; 2010b) and the 
porcine reproductive and respiratory syndrome virus (PRRSV) by Gregg et al. (2011) with the main 
conclusion that such a risk is reduced to very low (negligible) levels when appropriate precautions are 
adopted in the SCNT embryo production and transfer.  2012 Update on cloning of farmed animals
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Similar conclusions have been reached through an assessment of a considerable amount of 
experimental data on the transmission, via SCNT embryos, of porcine reproductive and respiratory 
syndrome virus by Gregg et al. (2011) and of equine infectious anaemia virus by Gregg and Polejaeva 
(2009) and by Asseged et al. (2012). 
 
One source of alteration to reprogramming with potential consequence on disease affecting SCNT 
offspring remains still poorly documented. It deals with sequences of retroviral origin that occupy 
approximately 10% of mammalian genomes. Endogenous retroviruses are inactivated by mutations 
and/or deletions but endogenous terminal repeat (LTR) retrotransposons are markedly activated 
during zygotic genome activation. This suggest a general requirement for retrotransposon 
transcription for progression through cleavage as shown recently by genome-scale, base-resolution 
analysis of DNA methylation at the cleaving stage of embryonic development in the mouse (Smith et 
al., 2012). Since SCNT involves nuclear remodelling and genome re-activation, this might influence 
or be influenced by the activation of retrotransposons. 
  A.5 Transfer into in vivo environment 
 
In a large scale retrospective analysis of the transfer conditions of SCNT embryos in the pig, involving 
100 to 300 recipients per variable considered, Koo et al. (2010) showed that the environment of the 
recipients and the technique of SCNT embryo transfer per se, are important determinants of cloning 
efficiency. The transfer of day-2 SCNT embryos in the oviduct of pre-ovulatory instead of post-
ovulatory recipients resulted in a significant increase in their pregnancy rate at day 25 (36.2% instead 
of 22.7%) and a marked 4.4 time increase in the rate of full-term pregnancies (9.4% and 2.1% 
respectively). Season also appeared to influence the in vivo development of porcine embryos (52% 
pregnancy rate after the transfer of SCNT embryos in autumn and only 18% in winter) and delivery 
rates (12.7% in spring but 4.3% in autumn); other parameters (embryo transfer (ET) method, 
prevention of cold shock to embryos before transfer prove to be also of importance.  
  A.6 Analysis of foetal and placental development: epigenetics and late emerging effects  
 
Abnormal implantation and placenta formation are frequently observed after the transfer of SCNT 
embryos into recipients. They contribute to the low efficiency of cloning and are the main origin of 
most of the health and welfare problems encountered by recipients at or before birth. Incomplete 
nuclear re-programming after SCNT and failure to re-establish appropriate epigenetic marks during 
development, particularly in regions controlling the expression of imprinted genes, are considered as 
the major causes of pregnancy failure with SCNT embryos. Some improvements have been made over 
the past two years to the analysis of pregnancy dysfunctions but these have not yet led to marked 
improvements in the reduction of pregnancy failures with SCNT embryos in farmed animals.  
 
•  Pre-implantation period up to placenta formation 
In cattle about 40% of transferred SCNT cattle blastocysts fail to develop through the elongation stage 
which initiates at day 14 (after the one-cell stage) and leads to implantation around day 18. Numerous 
factors, including recipient type, number of embryos transferred per recipient and season, have 
previously been shown to affect the in vivo development of SCNT embryos.  
 
Smith et al. (2010) found that gene expression profiles during the second week of embryogenesis do 
not differ between SCNT and IVF embryos. For that, the authors have transferred into the same 
recipient groups of 10 SCNT blastocysts obtained from a donor cell line harbouring a reporter gene 
(GFP) together with 5 (grade and stage matched, day 7) IVF blastocysts. Doing so, they provided the 
same in vivo environment to all the embryos while being able to screen for SCNT versus IVF embryos 
at recovery after 2, 4, 7 and 10 days. Gene expression profiles of nine trophoblast and two epiblast 
relevant marker genes were found to be similar between SCNT and IVF embryos of the same 
trophoblast length. Thus the gene expression program that regulates the critical phase of embryo 
elongation is spatially and temporally correctly reprogrammed in the SCNT blastocysts up to the 2012 Update on cloning of farmed animals
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initiation of implantation. Consequently the reduced birth rates with SCNT embryos compared to IVF 
embryos must be predominantly due to reprogramming-specific errors manifesting their effect after 
implantation. In other words the SCNT related defects observed at later developmental stages have to 
be considered as predominantly of epigenetic origin. 
 
A further step was taken by Degrelle et al. (2012), who proposed that gene expression pattern in the 
extra-embryonic tissues at implantation (day 18) do not reflect the pregnancy outcome while that of 
the embryo itself does. For this conclusion, the authors made a general analysis of the genes expressed 
from the extra-embryonic part of bovine SCNT-derived embryos at day 18 using a dedicated array of 
10214 unique sequences. These were obtained from the cDNAs of extra-embryonic tissues of bovine 
embryos collected at different developmental stage between day 14 and day 24 as well as cDNAs from 
young foetuses (day 36 - day 64) and from term placenta. Expression patterns were compared between 
SCNT,  in vitro fertilized and AI derived (in vivo fertilized) embryos. The general patterning 
(gastrulation) of the embryonic part of each embryos was also analysed. Finally and in order to 
provide an insight into the interactions between the expression profile of embryonic versus extra-
embryonic tissues within the same embryo they use day 18 SCNT embryos obtained from 3 different 
donor cell lines (10 embryos per line) already known from their ability to provide similar rates of 
blastocysts (rates higher than 30% from reconstructed 1-cell stage embryos) but highly different 
calving rates (respectively 2.3%, 6.1% and 20%). From this multifactorial analysis they discovered 
that the embryonic part of SCNT embryos exhibited 20 to 60% of abnormalities that mirrored the 
different pregnancy rates and recalled some defective specification of the primitive streak whereas the 
extra embryonic part was still functionally normal since only a low proportion of genes (72 out of the 
10 000 unique sequences analysed) were surprisingly found to be differentially expressed between the 
groups of embryos including in vivo produced ones. From those genes, only 7 were classified as of 
importance to nuclear reprogramming and cell differentiation. Thus an uncoupling between the extra-
embryonic functions, mostly normal at day 18 and the embryonic functions, already altered at 
gastrulation, is an ontological mark of developmental failures after SCNT. 
 
An additional observation of the pattern of expression of a small set of genes expressed at later 
stages of pregnancy (day 26 and day 63) in differentiated extra-embryonic tissues (yolk sac and 
chorion) suggested that a reduced expression of key regulatory genes could be at the origin of the 
dysfunctions of SCNT clones. A similar situation is observed also in the pig. In their analysis of the 
effect of activation procedure on SCNT embryo development, Whitworth et al. (2010) studied several 
functional activities of the extra-embryonic membranes of SCNT and control day-30 conceptus. Up-
regulated pathways in SCNT extra-embryonic membrane included blood circulation and gas exchange, 
cell surface receptor-mediated signal transduction, G-protein and ligand mediated signalling. Major 
histocompatibility class 1 genes were both up- and down-regulated suggesting that there are major 
differences in reproductive tract immunity between conventional  and clone pregnancies in pig. 
Interestingly, PAG2, a trophoblast-specific transcript was found to be ectopically expressed in the 
luminal epithelium of the maternal side with SCNT conceptus but not with in vivo produced embryos. 
This is potentially an important observation since PAG2 is a member of a large family of pregnancy 
associated glycoproteins.  
 
Further insights into the he causal origin of gestational death of pig SCNT conceptus was provided by 
Kim et al. (2011). These authors analysed 12 SCNT foetuses obtained from 5 recipients at day 30 post 
transfer. All SCNT foetuses were alive and of normal size and shape but their foetal membranes 
displayed avascularisation and hypovascularisation. Several placenta related proteins were barely 
detectable at the basement membrane of the SCNT cytotrophoblast cells whereas they were markedly 
expressed in the cytotrophoblasts of developing controls. Genes were also down regulated with 
evidence of hypermethylated pattern of their promoter region (ex MMP9) and poor 
immunohistochemical staining. Some genes however (exHand-1) were over expressed while others 
were expressed similarly to controls. Evidence of a marked apoptosis in the developing endometrial 
gland of the recipient transferred with SCNT embryos was also provided. The authors conclude that 
death of pig SCNT conceptus is caused, at least in part, by disruption of the developing endometrial 
gland due to impaired trophoblast migration and invasiveness. 2012 Update on cloning of farmed animals
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In summary, the above results lead to the view that early gestational death of SCNT conceptus (cattle 
and pig) stems from an initial uncoupling of developmental functions between the embryonic and 
extra-embryonic compartments of the implanting embryo. All the functions are not altered but the first 
perturbations influence tissue growth and differentiation within each compartment.  
 
•  Early placenta development 
Abnormal placentation associated with hydrallantois and foetal overgrowth, known as the large 
offspring syndrome (LOS) account for most of the foetal losses observed in cattle in the mid to late 
gestation period after SCNT. During the period of the initiation of placentome formation (day 35-
50), SCNT embryos can show impaired cotyledon formation but also advanced cotyledon 
development and vascularisation. Many of the cotyledon - caruncle interactions fail to successfully 
form placentomes, resulting in far fewer placentomes. Overall, placentome numbers and morphology 
are far more variable in SCNT pregnancies compared to artificially inseminated (AI) controls, 
suggesting a deregulation of placental development. References are Guillomot et al. (2010) on Phlda2 
gene with data from day 32 to day 200 and Kohan-Ghadr et al. (2012) on E-cadherin and b catenin at 
the attachment period. 
 
•  Late placenta development 
Foetal losses continue to occur sporadically throughout the second and third trimesters in bovine 
SCNT pregnancies, affecting 25 to 75% of pregnancies from Day 90 onwards. Whether the numbers 
of placentomes are decreased or are normal, there is increased total placental mass and the enlarged 
placentomes are much larger and thicker in these pregnancies and develop hydrallantois (a rapid and 
uncontrolled increase in allantoic fluid volume) and oedema of the foetal membranes and placental 
tissues. Hydrallantois accounts for most of the foetal mortality in the second half of gestation in 
bovine SCNT compared to <1% in normal bovine pregnancies. These placental abnormalities are 
additionally associated with other foetal lesions, such as enlarged umbilical cord and ascites (excessive 
fluid accumulation in the abdominal cavity), cardiac enlargement, liver steatosis and renal lesions, 
such as hydronephrosis, all of which compromise foetal viability. References for cattle are Yan et al. 
(2010) on mitochondrial compatibility at day 90 of gestation and Takeda et al. (2011) on liver 
mitochondrial status in new born calves. A reference for pigs is Wei et al. (2010) on Methylation 
status of placenta tissues at birth in the pig.  
  A.7 Future developments and expectations for additional research 
 
The efforts that are being made in the scientific community to overcome the identified processes that 
work sub-optimally during the cloning of farmed mammals, have lead over the past two years to some 
improvement in the development of early SCNT embryos and a more comprehensive description of 
the failures affecting placental function compromising foetal development. It is also confirmed that 
species differences in terms of the kinetics of pre-implantation development, in vitro culture 
requirement, and timing of implantation and duration of gestation have to be taken into account to 
steadily lead to improvements in cloning efficiency.  
 
Recent publications in the mouse species offer promising prospects also for mammalian SCNT 
cloning. They provide convincing evidence that marked improvement in terms of live offspring 
obtained from transferred SCNT embryos is becoming an achievable goal at least in mouse. Since 
these reports also offer a conceptual framework for the unravelling of the complex events linked to the 
remodelling and reprogramming of somatic nuclei, they support basic research with the more 
demanding (in terms of replication time and consequently research costs) farmed animals. 
 
First, the group of Ogura et al. (Inoue et al., 2010; Matoba et al., 2011) identified an RNA which 
appears to act as a general key regulator of the level l of expression of many genes during early 
development and leading to impaired development of mouse clones. By injecting oocytes just before 
SCNT or at the pronuclear stage with a siRNA against Xist, a gene responsible for X chromosome 
inactivation (XCI), they obtained evidence of a seven- to nine-fold increase in overall cloning 2012 Update on cloning of farmed animals
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efficiency compared to non-treated controls. From 304 2-cell stage embryos injected in different 
experiments performed by different operators 45 live pups were delivered (overall efficiency 14.8%) 
whereas the transfer of 293 control embryos resulted in only 6 live pups (overall efficiency 2%). A 
synergetic treatment of siRNA injected embryos with TSA to overcome some of the non-random 
errors in genome reprogramming resulted in an overall efficiency of 20% (14 live pups from 69 treated 
embryos versus only 4 pups from 68 control embryos). Moreover, only limited gene dysregulations 
were observed in the gene expression profiles of livers in neonate clones supporting the view that 
correction of Xist expression in pre-implantation embryos might have long-term beneficial effects 
during postnatal life. It has been shown recently that different mammals have very different strategies 
for initiating X-chromosome inactivation, for example eutherian mammals including rabbit (and 
human) have very different strategies for initiating X chromosome inactivation (Okamoto et al., 2011).  
 
Second, Balbach et al. (2012) provided a comprehensive study of the cell cycle during early phases of 
reprogramming after SCNT. Using bright field and live fluorescence imaging of histone H2b-GFP 
expressing mouse embryos to quantitavely analyse cleavage kinetics up to the blastocyst stage, they 
showed that SCNT embryos presented similar rates of errors in M phase than in vitro (ICSI) 
fertilized controls, but were considerably less tolerant to subsequent mitotic errors. While this 
does not affect pre-implantation development, it has detrimental consequences at post-implantation 
stages. Different needs of SCNT and control embryos in terms of amino acid supplementation 
(arginine) was also outlined in the Balbach’s paper.  
 
From these reports above (Ogura et al. and Balbach et al.), the view emerges that contrarily to the 
current assumption, the fate of mouse clone embryos is largely if not almost exclusively 
determined before implantation. Bright field microscopy and live imaging of chromatin remodelling 
of embryos during the first mitosis are useful new tools for screening of SCNT embryos with a high 
developmental potential, before their transfer in vivo. 
 
This has important consequences for research with farmed animals where the late emerging effects of 
SCNT markedly affect both surrogate dam and clone health and welfare. Under the hypothesis that the 
basic mechanisms underlying reprogramming in mammals are well conserved between species (a 
reasonable assumption) the above assumption indicates that a research on the early cellular and 
molecular events of SCNT could lead to more rapid improvement in terms of health and welfare. 
 
•  Prediction of pregnancy outcome  
Not only for the particular field of cloning, research is evolving to predict pregnancy outcome and 
full-term development of foetuses, for instance with 3D imaging. Also the developmental potential of 
SCNT embryos into live offspring remains today largely unpredictable. While most gestational losses 
occur during the pre-implantation period, the prevalence and severity of abnormal placentation and 
late foetal losses is a matter of concern for applications of cloning. Attempts to predict pregnancy 
outcome after SCNT embryo transfer remains an important objective. Few improvements have 
however been obtained over the past two years. 
 
At late foetal stages, the mean umbilical vessel diameter is consistently larger in SCNT compared to 
control AI pregnancies. Le Cleac'h (2011) used the non-invasive ultrasound imaging to provide 
evidence that not only the diameter of umbilical vessels but also rib sizes and interval between two 
consecutive ribs were higher in clones from the 5th month of pregnancy onwards. For that he used 2D 
Doppler technique to monitor the pregnancies established with clones (n= 7) or after insemination 
(n=11). Evaluation of placentome morphology and size, echogenicity of allantoic fluid, rib sizes and 
interval between two consecutive ribs, diameter of umbilical vessels, were recorded from a mean of 
4.8 sessions per animal and 2 placentome analysed per session. Only the last two parameters were 
found to be higher in clones already at 5 month and up to term.  
This approach has been extended to a quantitative evaluation of blood flow within the placentome 
unit the sheep by Morel et al. (2010). Although these authors did not have examined yet pregnancies 
established from SCNT embryos, their work provides a first demonstration that several Power Doppler 2012 Update on cloning of farmed animals
 
EFSA Journal 2012;10(7):2794  32
Angiography (PDA) indices can be used in vivo to monitor placental functions. Advances in the 
medical use of imaging techniques should prove to be helpful for increasing the prognostic evaluation 
of pregnancy outcome in clones. 
Earlier prediction of pregnancy outcome with clones has been proposed by Constant et al. (2011) who 
analysed the plasma levels of pregnancy associated glycoproteins (PAG) produced by the placental 
trophoblast in ruminants. These glycoproteins are known to migrate to the uterine luminal epithelium. 
These authors found that with abnormal SCNT pregnancies, maternal PAG concentrations are higher 
compared to conventional pregnancies established after AI or IVF from the end of the second month 
of pregnancy (day 62) onwards. This was shown using three different immunoassay quantifications 
measuring the level of PAG-1 (67kDa) in the peripheral blood. They also provide some evidence that 
this increase is not the result of an increase in protein expression of PAG-1 and propose that altered 
secretion (clearance) of the glycoprotein rather explains this result. This approach could constitute the 
detection of abnormal SCNT pregnancies in cattle already from the end of the second trimester.  
Attempt for an even earlier prediction of pregnancy outcome already at implantation has been 
proposed by Degrelle et al. (2011) in cattle. These authors examined whether a molecular signature 
originating from extra-embryonic tissues could relate to the developmental stage of the embryo 
proper and be used to predict its full term development. To this end, these authors analysed the 
expression profile of day 18 extra-embryonic tissues which can be sampled from in vivo developing 
conceptus. They had previously identified a set of seven extra-embryonic genes which were 
discriminative to distinguish between two different consecutive development stages of embryonic 
patterning (at gastrulation and early neurulation). Abnormal patterning at implantation is a major 
bottleneck to full reprogramming of SCNT embryos. To determine if the expression profile of the 
extra-embryonic compartment could be used to predict the status of the embryonic compartment they 
examined 15 day-18 SCNT embryos collected in vivo. They found that the normality of the patterning 
process could be accurately predicted for 14 out of the 15 embryos (accuracy of 93%) with a panel of 
only 6 extra-embryonic expressed genes.  
In the pig, methylation status of early embryos has also been proposed by Niemann et al. (2010) to 
evaluate the quality of SCNT blastocysts. A comprehensive study on epigenetic reprogramming that 
occurs in ARTs was conducted by comparing 25 developmentally important genes of in vitro (IVF and 
SCNT) and in vivo (AI) bovine embryos. The study revealed a subset of amplicons that distinguished 
between the three groups. This subset of amplicons can be used to evaluate blastocyst quality and 
reprogramming following SCNT, and can also be employed for the localization of the epigenetic 
control regions within individual genes. 
•  Health prognosis of growing foetuses 
Further to the prediction of pregnancy term as mentioned above, prediction methods are also used for 
making health prognosis of growing foetuses, for proposing improvements to the conditions in the 
uterus and for adaptation of foetuses to their uterine environment. This can be achieved for instance by 
real-time echography to monitor the development of the foetus in association with the 
management of the surrogate dam, adjusted to the developmental needs of the growing foetus. By 
modifying the diet of the surrogate dams, meeting the nutritional requirements of the surrogate dam 
during the pregnancy, and altering the management of the mothers, the growth of the foetal clones 
could be influenced. Applying these methods during cloning, aims to overcome some of the animal 
health and welfare challenges of cloning, such as LOS in cattle, and eventually aim at more live SCNT 
clone births. 2012 Update on cloning of farmed animals
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ABBREVIATIONS 
AI: Artificial Insemination 
ART: Assisted Reproductive Technology 
BVDV: Bovine Viral Diarrhoea Virus  
CHL/IU: Chinese Hamster Lung Cells  
CP: Cloned Progeny 
CPC: Chromosomal Passenger complex   
CV: Conventional animals 
C1: First generation Clone 
C2: Second generation Clone, cloned from a first generation clone 
F1: First generation 
F2: Second generation 
ECNT: Embryonic Cell Nuclear Transfer 
h: hour  
IVF: In vitro Fertilization 
IVP: In vitro Production 
LM: Longissimus Muscle 
LOS: Large Offspring Syndrome 
LW: Large White  
MOET: Multiple Ovulation Embryo Transfer 
N: Number 
mtDNA: Mitochondrial DNA 
ROS: Reactive Oxigen Species 
SCNT: Somatic Cell Nuclear Transfer 
vs: versus 
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GLOSSARY  
Term  Definition used in the opinion
Allele  A gene that occupy a particular chromosomal locus. A diploid 
organism has two alleles, one on each chromosome. 
Blastomere  Any one of the cells formed from the first few cell divisions in 
animal embryology. The embryo usually divides into two, then 
four, then eight blastomeres, and so on. 
Blastocyst  The early stage in the development of mammalian embryos. The 
blastocysts have an inner cell mass which will become the foetus 
and an outer cell mass (trophectoderm) that will become part of 
the placenta.  
Caesarean section  Birth by surgical intervention. 
Chromatin  The complex of DNA and various proteins that makes up the 
chromosomes. 
SCNT-derived embryo, SCNT 
embryo, embryo clone 
Embryo resulting from somatic cell nuclear transfer. 
CpG  A region of DNA where a Cytosine nucleotide is separated by a 
phosphate to Guanine nucleotide. A CpG island is a region which 
has a high concentration of CpG sites.  
Cytoplasm  The living content of the cell, except the nucleus, consisting of an 
aqueous protein matrix or gel, and where vital cellular organelles 
(e.g. mitochondria) are located. 
DNA methylation  Biochemical modification to the DNA through the addition of a 
methyl group. 
Donor animal  Animal from which the cell is obtained to be used in the cloning 
procedure. 
Dystocia  Abnormal or difficult birth giving or labour. 
Embryo  A multicellular structure of diploid cells formed after fertilization 
of the oocyte and until all organs have been formed, when it is 
called a foetus. 
Embryo, Reconstructed   An embryo that has been reassembled from its component parts 
by micro manipulations in vitro. 
Epigenetic processes  Alteration of gene expression by biochemical modifications (e.g. 
methylation) of the DNA or of DNA-binding proteins. The 
process does not involve changes in the DNA sequence. 
Epigenetic dysregulation  Abnormal or impaired control of gene expression. 
Epi-alleles  Alleles that are epigenetically modified. 
Fibroblast  A cell found mainly in connective tissue, involved in the 
formation and synthesis of extracellular matrix (e.g. collagen 
fibres). 
Foetus  A developing mammal after the embryo stage and before birth. 
Gamete  A mature reproductive cell from a male or female containing a 
haploid number of chromosomes that normally fuses with another 
gamete from the opposite sex to form a zygote (diploid) from 
which a new organism can develop. The oocyte and 
spermatozoon are gametes. 
Gametogenesis  The process of the formation of haploid gametes. 
Genetic diversity  The total number of genetic characteristics in the genetic make up 
of a species. 
Genotype  The entire genetic constitution of an individual. 
Germ line cell   A reproductive cell such as a spermatocyte or an oocyte, or a cell 
that will develop into a reproductive cell. 
Heteroplasmy  The presence of a mixture of more than one type of an organellar 
genome (e.g. mitochondrial DNA (mtDNA)) within a cell.  
Healthy  Within the range of zootechnical and physiological parameters of 
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and animal health. 
Heifer  A female bovine that has not yet produced a calf. 
Hydroallantois  Abnormal fluid accumulation in the allantoic cavity of the 
placenta. 
Hydronephrosis  Abnormal fluid accumulation in the kidney.  
Hydrops fetalis  A condition in the foetus characterized by accumulation of fluid, 
in at least two compartments (e.g. subcutaneous tissue, pleura, 
pericardium, abdomen). Hydrops sometimes leads to spontaneous 
abortion. 
Imprinting  A genetic phenomenon by which certain genes are expressed in a 
parent-of-origin specific manner.  
Juvenile period  A period referring to young bovine of up to six months of age. 
Large Offspring Syndrome (LOS)  The  size  of  the  offspring is greater than mean + 2SD for the 
species or breed. Symptoms include clinical hydrops, placental 
oedema and asynchronous growth of organs resulting in increased 
heart and liver size. 
Natural life span  The typical length of time an individual of a particular species can 
be expected to live. 
Oocyte  Unfertilized egg, the female gamete. 
Oocyte donor  Animal providing the oocyte used in the cloning procedure. 
Parturition   The act or process of giving birth to offspring. 
Perinatal period  A species dependent time period around 7 days before and after 
birth for livestock. 
Phenotype  The totality of the observable and structural characteristics of an 
organism as determined by genotype and its interaction with the 
environment. 
Placentome number  The number of interfaces between the cotyledons of the foetus 
and the caruncles of the dam’s uterus forming the cotyledonary 
placenta in ruminants. 
Pluripotent  The possibility of a stem cell to differentiate into any of the three 
germ layers. A pluripotent cell can give rise to any foetal or adult 
cell type but has not the potential of as a totipotent cell. 
Postnatal period  Time period (a few days) after birth. 
Progeny  of  clone  F1 and subsequent generations of animals born by sexual 
reproduction where at least one of the ancestors was a clone 
animals. Progeny is used interchangeably herein with Offspring.  
Sexual reproduction  Normal way of reproduction between male and female, involving 
fusion between spermatozoon and oocyte. 
Silent  mutation  DNA mutations that do not result in amino acid changes in a 
protein. 
Somatic cell  Any cell of an animal that is not a germ line cell. 
Surrogate dam  Animal carrying the SCNT-derived embryos. 
Telomere  A region of highly repetitive DNA at the end of a chromosome. 
Totipotent  The possibility of a single cell to divide into any differentiated 
cell. See also pluripotent. 
Transgene  Foreign genetic material inserted, e.g. in a cell, embryo or 
organism (also: genetically modified). 
Trophectoderm The  group  of  cells in the blastocyst that form the placenta.  
Zona pellucida  The thick glycoprotein layer surrounding the plasma membrane of 
an oocyte. 
Zygote  The cell that results after fertilization of two haploid cells (usually 
a spermatozoon and an oocyte). 
 